ADRENAL.CANCER__CANCER-LIKE | GSE28476 | 8 | 7 | CANCER-LIKE | | 21565795 | Characterization of differential gene expression in adrenocortical tumors harbouring β-catenin (CTNNB1) mutations. |
ADRENAL.CANCER__CANCER-LIKE | E-TABM-311 | 107 | 68 | CANCER-LIKE | | 19139432 | Transcription profiling by array of human adrenocortical tumors to identify molecular predictors of diagnosis and prognosis |
ADRENAL.CANCER__CANCER-LIKE | GSE8514 | 15 | 9 | CANCER-LIKE | | 17911395 | Expression data from normal adrenal gland and aldosterone-producing adenoma |
ADRENAL.CANCER__CANCER | GSE12368 | 34 | 28 | CANCER | | 19218281 | Analysis of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas |
ADRENAL.CANCER__CANCER | GSE19750 | 48 | 44 | CANCER | | 24238056 | Adrenocortical Carcinoma Gene Expression Profiling [Affymetrix] |
ADRENAL.CANCER__CANCER | E-TABM-311 | 107 | 34 | CANCER | | 19139432 | Transcription profiling by array of human adrenocortical tumors to identify molecular predictors of diagnosis and prognosis |
ADRENAL.CANCER__CANCER | GSE33371 | 65 | 55 | CANCER | | 22800756 | Beta-catenin status effects in human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10) |
ADRENAL.CANCER__NORMAL | GSE12368 | 34 | 6 | NORMAL | - | 19218281 | Analysis of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas |
ADRENAL.CANCER__NORMAL | GSE7307 | 677 | 4 | NORMAL | - | - | Human body index - transcriptional profiling |
ADRENAL.CANCER__NORMAL | GSE19750 | 48 | 4 | NORMAL | - | 24238056 | Adrenocortical Carcinoma Gene Expression Profiling [Affymetrix] |
ADRENAL.CANCER__NORMAL | E-TABM-311 | 107 | 4 | NORMAL | - | 19139432 | Transcription profiling by array of human adrenocortical tumors to identify molecular predictors of diagnosis and prognosis |
ADRENAL.CANCER__NORMAL | GSE8514 | 15 | 4 | NORMAL | - | 17911395 | Expression data from normal adrenal gland and aldosterone-producing adenoma |
ADRENAL.CANCER__NORMAL | GSE43346 | 70 | 1 | NORMAL | - | 23714854 | Gene repression with H3K27me3 modification in human small cell lung cancer |
ADRENAL.CANCER__NORMAL | GSE33371 | 65 | 10 | NORMAL | - | 22800756 | Beta-catenin status effects in human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10) |
BILE.DUCT.CANCER__CANCER | GSE39409 | 32 | 15 | CANCER | | - | Gene expression profiling of ampullary carcinomas classifies ampullary carcinomas into biliary-like and intestinal-like subtypes that are prognostic of outcome |
BLADDER.CANCER__CANCER | E-MTAB-1803 | 171 | 85 | CANCER | | - | Bladder-RI |
BLADDER.CANCER__CANCER | GSE31684 | 93 | 92 | CANCER | | 22228636;24486590 | Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer |
BLADDER.CANCER__CANCER | E-MTAB-1940 | 87 | 82 | CANCER | | - | Expression profil of non-muscle invasive (superficial) bladder carcinoma |
BLADDER.CANCER__NORMAL | GSE11783 | 16 | 6 | NORMAL | - | 19400928 | Gene expression profile of bladder tissue of patients with ulcerative interstitial cystitis |
BLADDER.CANCER__NORMAL | E-MTAB-1940 | 87 | 4 | NORMAL | - | - | Expression profil of non-muscle invasive (superficial) bladder carcinoma |
BRAIN.TUMOR__CANCER | GSE37418 | 76 | 76 | CANCER | | 22722829 | Novel mutations target distinct subgroups of medulloblastoma. |
BRAIN.TUMOR__CANCER | GSE44971 | 58 | 48 | CANCER | | 23660940 | Gene expression data from pilocytic astrocytoma tumour samples and normal cerebellum controls |
BRAIN.TUMOR__CANCER | GSE2817 | 30 | 30 | CANCER | | 17140431 | Wavelet modelling of microarray data provides chromosomal pattern of expression which predicts survival in gliomas |
BRAIN.TUMOR__CANCER | GSE35493 | 71 | 18 | CANCER | | 23382118 | Pediatric rhabdoid tumors of kidney and brain show many differences in gene expression but share dysregulation of cell cycle and epigenetic effector genes |
BRAIN.TUMOR__CANCER | GSE64415 | 209 | 209 | CANCER | | 25965575 | Gene expression data from ependymal tumor samples |
BRAIN.TUMOR__CANCER | GSE49243 | 73 | 73 | CANCER | | 24871706;24651015;25024229 | Gene expression data from medulloblastoma tumor samples |
BRAIN.TUMOR__CANCER | GSE15824 | 45 | 30 | CANCER | | 21406405 | Gene expression profiling of human gliomas and human glioblastoma cell lines |
BRAIN.TUMOR__CANCER | GSE29796 | 72 | 52 | CANCER | | 23727239 | Transcriptional Differences between Normal and Glioma-Derived Glial Progenitor Cells Identify a Core Set of Dysregulated Genes. |
BRAIN.TUMOR__CANCER | GSE24244 | 8 | 8 | CANCER | | 21102433 | Gene expression profiling of four subpopulations in GBM |
BRAIN.TUMOR__CANCER | GSE12992 | 40 | 40 | CANCER | | 19197950 | Beta-catenin status in pediatric medulloblastomas |
BRAIN.TUMOR__CANCER | GSE19578 | 209 | 53 | CANCER | | 20479398;21659463 | Integrated molecular genetic profiling of pediatric-high grade gliomas reveals key differences with adult disease |
BRAIN.TUMOR__CANCER | GSE45921 | 22 | 22 | CANCER | | 23869222 | Expression data from human glioma tissues |
BRAIN.TUMOR__CANCER | GSE19404 | 24 | 23 | CANCER | | 23591193;23887970 | Gene expression analysis of primitive neuroectodermal tumors |
BRAIN.TUMOR__CANCER | GSE43289 | 40 | 40 | CANCER | | 20484145 | Gene expression profiles of gliomas with Affymetrix Human Genome U133 Plus 2.0 Array |
BRAIN.TUMOR__CANCER | GSE28238 | 40 | 40 | CANCER | | 23947815 | Low grade gliomas |
BRAIN.TUMOR__CANCER | E-TABM-898 | 57 | 56 | CANCER | | - | Transcription profiling of human glioblastomas (56 tumor samples) |
BRAIN.TUMOR__CANCER | GSE34824 | 27 | 18 | CANCER | | 22286061 | Frequent driver mutations in histone H3.3 and chromatin remodeling genes in paediatric glioblastoma |
BRAIN.TUMOR__CANCER | GSE9171 | 30 | 12 | CANCER | | 18394558 | Expression profiles of human glioblastoma frozen tumors and cell lines |
BRAIN.TUMOR__CANCER | GSE12141 | 2 | 2 | CANCER | | - | Metastasizing anaplasic ependymoma in an adult |
BRAIN.TUMOR__CANCER | GSE4290 | 180 | 9 | CANCER | | 16616334 | Expression data of glioma samples from Henry Ford Hospital |
BRAIN.TUMOR__CANCER | GSE5675 | 41 | 41 | CANCER | | 17283119 | Pilocytic astrocytoma |
BRAIN.TUMOR__CANCER | E-MTAB-951 | 25 | 22 | CANCER | | - | Genome and transcriptome study of the response to irinotecan and bevacizumab in recurrent glioblastomas (CIT - Homo sapiens - BEVA) |
BRAIN.TUMOR__CANCER | GSE53733 | 70 | 70 | CANCER | | 24615357 | Expression data from primary Glioblastoma in adults |
BRAIN.TUMOR__CANCER | GSE32374 | 21 | 3 | CANCER | | 22711608 | Clinical and Molecular Characteristics of Congenital Glioblastoma Multiforme |
BRAIN.TUMOR__CANCER | GSE26576 | 126 | 35 | CANCER | | 21931021 | Genome-wide Analyses of Diffuse Intrinsic Pontine Gliomas |
BRAIN.TUMOR__CANCER | GSE66354 | 149 | 136 | CANCER | | 25968456 | Investigation of the mechansim underlying the inflammatory phenotype in Group A ependymoma |
BRAIN.TUMOR__CANCER | GSE7696 | 84 | 10 | CANCER | | 18565887;21642372 | Glioblastoma from a homogenous cohort of patients treated within clinical trial |
BRAIN.TUMOR__CANCER | GSE19728 | 21 | 4 | CANCER | | 21836821 | Expression data from different grades (WHO) of astrocytomas (ACM) |
BRAIN.TUMOR__CANCER | E-MTAB-1852 | 43 | 16 | CANCER | | - | High-through put translational in vivo and ex vivo techniques for glioma molecular characterization and accurate classification, prognosis and treatment selection subset data from etumour consorteum Kal1 |
BRAIN.TUMOR__CANCER | GSE23806 | 92 | 12 | CANCER | | 21294158;18037961;25543125 | Expression data of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors |
BRAIN.TUMOR__CANCER | GSE36245 | 46 | 36 | CANCER | | 23079654 | Gene expression data from glioblastoma tumor samples |
BRAIN.TUMOR__CANCER | GSE13041 | 267 | 26 | CANCER | | 18940004 | Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age |
BRAIN.TUMOR__CANCER | GSE4536 | 101 | 3 | CANCER | | 16697959 | Tumor stem cells more closely mirror the phenotype and genotype of primary human tumors than do cancer cell lines |
BRAIN.TUMOR__CANCER | GSE21354 | 18 | 1 | CANCER | | 21836821 | gene expression profiling of three type of grade II gliomas |
BRAIN.TUMOR__CANCER | GSE61374 | 137 | 137 | CANCER | | 25783747 | Expression data from cerebral tumors of WHO grade II and III |
BRAIN.TUMOR__CANCER | GSE50161 | 130 | 22 | CANCER | | 24078694 | Expression data from human brain tumors and human normal brain |
BRAIN.TUMOR__CANCER | GSE10327 | 62 | 62 | CANCER | | 18769486 | mRNA expression data of 62 human medulloblastoma tumors |
BRAIN.TUMOR__CANCER | GSE50385 | 65 | 10 | CANCER | | - | Expression data from human ependymoma |
BRAIN.TUMOR__NORMAL | GSE44971 | 58 | 9 | NORMAL | - | 23660940 | Gene expression data from pilocytic astrocytoma tumour samples and normal cerebellum controls |
BRAIN.TUMOR__NORMAL | GSE35493 | 71 | 1 | NORMAL | - | 23382118 | Pediatric rhabdoid tumors of kidney and brain show many differences in gene expression but share dysregulation of cell cycle and epigenetic effector genes |
BRAIN.TUMOR__NORMAL | GSE15824 | 45 | 5 | NORMAL | - | 21406405 | Gene expression profiling of human gliomas and human glioblastoma cell lines |
BRAIN.TUMOR__NORMAL | GSE48350 | 253 | 173 | NORMAL | - | 18832152;23273601;22824372;20838618;23999428;23206327 | Alzheimer's Disease Dataset |
BRAIN.TUMOR__NORMAL | GSE43346 | 70 | 7 | NORMAL | - | 23714854 | Gene repression with H3K27me3 modification in human small cell lung cancer |
BRAIN.TUMOR__NORMAL | GSE19404 | 24 | 1 | NORMAL | - | 23591193;23887970 | Gene expression analysis of primitive neuroectodermal tumors |
BRAIN.TUMOR__NORMAL | GSE13564 | 44 | 44 | NORMAL | - | 19457239 | Gene expression in the human prefrontal cortex during postnatal development |
BRAIN.TUMOR__NORMAL | GSE5281 | 161 | 74 | NORMAL | - | 17077275;18332434 | Alzheimer's disease and the normal aged brain (steph-affy-human-433773) |
BRAIN.TUMOR__NORMAL | GSE7307 | 677 | 174 | NORMAL | - | - | Human body index - transcriptional profiling |
BRAIN.TUMOR__NORMAL | GSE28160 | 35 | 9 | NORMAL | - | 21909266 | Significant Effects of Antiretroviral Therapy on Global Gene Expression in Brain Tissues of Patients with HIV-Associated Neurocognitive Disorders |
BRAIN.TUMOR__NORMAL | GSE21935 | 42 | 19 | NORMAL | - | 21538462 | Comparison of post-mortem tissue from Brodman Brain BA22 region between schizophrenic and control patients |
BRAIN.TUMOR__NORMAL | GSE4757 | 20 | 10 | NORMAL | O | 16242812 | Alzheimer’s disease: neurofibrillary tangles (Rogers-3U24NS043571-01S1) |
BRAIN.TUMOR__NORMAL | GSE35864 | 72 | 18 | NORMAL | - | 23049970 | The National NeuroAIDS Tissue Consortium Brain Gene Array: Two types of HIV-associated neurocognitive impairment |
BRAIN.TUMOR__NORMAL | GSE7621 | 25 | 8 | NORMAL | - | 17571925 | Expression data of substantia nigra from postmortem human brain of Parkinson's disease patients (PD) |
BRAIN.TUMOR__NORMAL | GSE26576 | 126 | 2 | NORMAL | O | 21931021 | Genome-wide Analyses of Diffuse Intrinsic Pontine Gliomas |
BRAIN.TUMOR__NORMAL | E-MTAB-3073 | 551 | 28 | NORMAL | - | 19208739 | Molecular Analysis of Brain Neoplasia |
BRAIN.TUMOR__NORMAL | GSE66354 | 149 | 13 | NORMAL | - | 25968456 | Investigation of the mechansim underlying the inflammatory phenotype in Group A ependymoma |
BRAIN.TUMOR__NORMAL | GSE3526 | 353 | 46 | NORMAL | - | 16572319 | Comparison of gene expression profiles across the normal human body |
BRAIN.TUMOR__NORMAL | GSE18696 | 12 | 12 | NORMAL | - | 19922771 | Comparison of human lower and upper entorhinal cortex layers gene expression |
BRAIN.TUMOR__NORMAL | GSE19728 | 21 | 4 | NORMAL | - | 21836821 | Expression data from different grades (WHO) of astrocytomas (ACM) |
BRAIN.TUMOR__NORMAL | GSE53890 | 41 | 41 | NORMAL | - | 24670762 | REST and Stress Resistance in Aging and Alzheimer’s Disease |
BRAIN.TUMOR__NORMAL | GSE21354 | 18 | 4 | NORMAL | - | 21836821 | gene expression profiling of three type of grade II gliomas |
BREAST.CANCER__CANCER | GSE29431 | 66 | 54 | CANCER | | - | Identifying breast cancer biomarkers |
BREAST.CANCER__CANCER | GSE20711 | 90 | 88 | CANCER | | 21910250 | Epigenetic portraits of human breast cancers (expression data) |
BREAST.CANCER__CANCER | GSE21422 | 19 | 14 | CANCER | | 21314937 | Expression profiling of human DCIS and invasive ductal breast carcinoma |
BREAST.CANCER__CANCER | GSE7515 | 26 | 11 | CANCER | | 19666588 | Gene expression data from cancer mammospheres and bulk tumors |
BREAST.CANCER__CANCER | GSE43502 | 25 | 25 | CANCER | | 23549873 | Identification of Prognosis-Relevant Subgroups in Patients with Chemoresistant Triple Negative Breast Cancer |
BREAST.CANCER__CANCER | GSE50948 | 156 | 156 | CANCER | | 24443618 | Expression Data from transNOAH breast cancer trial |
BREAST.CANCER__CANCER | GSE22544 | 20 | 16 | CANCER | | 20799942 | Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast: expression analysis |
BREAST.CANCER__CANCER | GSE22513 | 28 | 28 | CANCER | | 20068102;21633166;20878462 | Markers of Taxane Sensitivity in Breast Cancer |
BREAST.CANCER__CANCER | GSE10810 | 58 | 31 | CANCER | | 20029976 | Gene expression signatures in breast cancer distinguish phenotype charact., histological subtypes, and tumor invasivness |
BREAST.CANCER__CANCER | GSE28821 | 89 | 89 | CANCER | | 21633166 | Laser-capture microdissected invasive micropapillary carcinomas of the breast |
BREAST.CANCER__CANCER | GSE23593 | 50 | 50 | CANCER | | 20368555 | Intratumor Heterogeneity and Precision of Microarray-Based Predictors of Breast Cancer Biology and Clinical Outcome |
BREAST.CANCER__CANCER | GSE6532 | 741 | 87 | CANCER | | 17401012;18498629;20479250 | Definition of clinically distinct molecular subtypes in estrogen receptor positive breast carcinomas using genomic grade |
BREAST.CANCER__CANCER | GSE33658 | 22 | 22 | CANCER | | 21792626 | A phase II neoadjuvant trial of anastrozole (A), fulvestrant (F) and gefitinib (I - iressa) in patients with newly diagnosed estrogen receptor positive breast cancer |
BREAST.CANCER__CANCER | GSE12276 | 204 | 203 | CANCER | | 19421193 | Expression data from primary breast tumors |
BREAST.CANCER__CANCER | GSE47109 | 246 | 246 | CANCER | | 23774991 | BreastPRS is a Gene Expression Assay that Stratifies Intermediate-Risk Oncotype DX Patients into High or Low-Risk for Disease Recurrence |
BREAST.CANCER__CANCER | GSE58812 | 107 | 107 | CANCER | | 25887482 | Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response |
BREAST.CANCER__CANCER | GSE26639 | 226 | 226 | CANCER | | 21631949 | Expression Data from 226 patients of the REMAGUS02 trial |
BREAST.CANCER__CANCER | GSE42568 | 121 | 104 | CANCER | | 23740839 | Breast Cancer Gene Expression Analysis |
BREAST.CANCER__CANCER | GSE7307 | 677 | 5 | CANCER | | - | Human body index - transcriptional profiling |
BREAST.CANCER__CANCER | E-MTAB-1547 | 211 | 11 | CANCER | | - | Inflammatory Breast Cancer |
BREAST.CANCER__CANCER | GSE28796 | 24 | 24 | CANCER | | 21633166 | Gene expression profiles of pretreatment biopsies from dose-dense-docetaxel-treated breast cancers |
BREAST.CANCER__CANCER | GSE17907 | 109 | 12 | CANCER | | 20932292 | Molecular profiling of ERBB2-amplified breast cancers |
BREAST.CANCER__CANCER | GSE12763 | 30 | 30 | CANCER | | 19567590;21673316 | Gene expression profiling of 30 human breast cancers |
BREAST.CANCER__CANCER | E-MTAB-365 | 1191 | 494 | CANCER | | 21785460 | Transcription profiling by array of breast cancer samples to define breast cancer subsets |
BREAST.CANCER__CANCER | GSE21653 | 266 | 134 | CANCER | | 20490655;22110708 | A gene expression signature identifies two prognostic subgroups of basal breast cancer |
BREAST.CANCER__CANCER | GSE36771 | 107 | 107 | CANCER | | 22564725 | Expression data from primary breast tumors (Auckland) |
BREAST.CANCER__CANCER | GSE65194 | 178 | 153 | CANCER | | 25848952;23700430;23144294 | Expression profiling of breast cancer samples from Institut Curie (Maire cohort) --Affy CDF |
BREAST.CANCER__CANCER | GSE13787 | 23 | 2 | CANCER | | 19055754 | Frequent PTEN genomic alterations and activated PI3K pathway in basal-like breast cancer |
BREAST.CANCER__CANCER | GSE23720 | 370 | 197 | CANCER | | 21339811;22110708 | High-resolution comparative genomic hybridization of inflammatory breast cancer and identification of candidate genes |
BREAST.CANCER__CANCER | GSE28826 | 28 | 28 | CANCER | | 23326553 | Differentially expressed genes after treatment with chemotherapy in breast cancer and their correlation with pathologic bad response (Miller & Payne grades 1 and 2) |
BREAST.CANCER__CANCER | GSE11001 | 30 | 30 | CANCER | | 21339180 | Genome-wide expression profiling from formalin-fixed paraffin-embedded breast cancer core biopsies |
BREAST.CANCER__CANCER | E-MTAB-1006 | 97 | 96 | CANCER | | 17848951;19010862;20664596;20830311;22353773 | Comparison of human Inflammatory and non-Inflammatory breast cancer samples |
BREAST.CANCER__CANCER | GSE17700 | 64 | 32 | CANCER | | 20697068 | Factorial study for evaluating the effect of Affy platform and lab on gene expression measurements |
BREAST.CANCER__CANCER | GSE20685 | 327 | 327 | CANCER | | 21501481 | Microarray-based molecular subtyping of breast cancer |
BREAST.CANCER__CANCER | GSE54002 | 433 | 417 | CANCER | | 25214461 | Gene expression profiling of LCM captured breast cancer cells |
BREAST.CANCER__CANCER | GSE22035 | 43 | 43 | CANCER | | 21209903 | Gene expression data in estrogen receptor alpha positive breast tumors with and without PIK3CA mutations. |
BREAST.CANCER__CANCER | GSE18728 | 61 | 61 | CANCER | | 20012355 | Expression data from human breast cancers pre and post chemothrapy |
BREAST.CANCER__CANCER | GSE7904 | 62 | 42 | CANCER | | 16473279 | Expression data from human breast tissue |
BREAST.CANCER__CANCER | GSE10780 | 185 | 42 | CANCER | | 19266279 | Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue |
BREAST.CANCER__CANCER | GSE52322 | 37 | 37 | CANCER | | 16467094 | Novel linkages between DCE-MRI and genomic profiling in locally advanced and inflammatory breast cancer |
BREAST.CANCER__CANCER | GSE31192 | 33 | 20 | CANCER | | 23479404 | Molecular Signature of Pregnancy Associated Breast Cancer (PABC) |
BREAST.CANCER__CANCER | GSE28583 | 20 | 19 | CANCER | | 23326553 | Differentially expressed genes after treatment with chemotherapy in breast cancer and their correlation with pathologic mid-response (Miller & Payne grade 3) |
BREAST.CANCER__CANCER | GSE18864 | 84 | 84 | CANCER | | 20100965;20098429;20189874 | Tumor expression data from neoadjuvant trial of cisplatin monotherapy in triple negative breast cancer patients |
BREAST.CANCER__CANCER | GSE16391 | 55 | 55 | CANCER | | 19573224 | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
BREAST.CANCER__CANCER | GSE50567 | 41 | 35 | CANCER | | 21196292 | BRCA1-related gene signature in breast cancer: the role of ER status and molecular type |
BREAST.CANCER__CANCER | GSE48390 | 81 | 81 | CANCER | | 24098497 | Concurrent Gene Signatures for Han Chinese Breast Cancers [Affymetrix] |
BREAST.CANCER__CANCER | E-MTAB-748 | 182 | 46 | CANCER | | - | Expression and CGH array profiling of ductal carcinoma (135 tumor samples) |
BREAST.CANCER__CANCER | E-TABM-854 | 80 | 74 | CANCER | | - | Transcription profiling of human ductal and lobular breast cancers with familial or Cowden disease history. |
BREAST.CANCER__CANCER | GSE47389 | 47 | 47 | CANCER | | 23993096 | Towards understanding breast cancer mechanisms to metastasize |
BREAST.CANCER__CANCER | E-MTAB-566 | 75 | 74 | CANCER | | - | celecoxib-treated vs control breast tumours |
BREAST.CANCER__CANCER | GSE23177 | 116 | 116 | CANCER | | 21116709 | Prediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAs. |
BREAST.CANCER__CANCER | GSE10281 | 36 | 36 | CANCER | | 19666588 | Letrozole (Femara) early response to treatment |
BREAST.CANCER__CANCER | GSE43358 | 57 | 57 | CANCER | | 25412710 | Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technology |
BREAST.CANCER__CANCER | GSE5764 | 30 | 10 | CANCER | | 17389037 | Analysis of microdissected invasive lobular and ductal breast carcinomas in relation to normal ductal and lobular cells |
BREAST.CANCER__CANCER | GSE5460 | 129 | 94 | CANCER | | 18297396 | Predicting Features of Breast Cancer with Gene Expression Patterns |
BREAST.CANCER__NORMAL | GSE29431 | 66 | 12 | NORMAL | - | - | Identifying breast cancer biomarkers |
BREAST.CANCER__NORMAL | GSE20711 | 90 | 2 | NORMAL | - | 21910250 | Epigenetic portraits of human breast cancers (expression data) |
BREAST.CANCER__NORMAL | GSE21422 | 19 | 5 | NORMAL | - | 21314937 | Expression profiling of human DCIS and invasive ductal breast carcinoma |
BREAST.CANCER__NORMAL | GSE54002 | 433 | 16 | NORMAL | - | 25214461 | Gene expression profiling of LCM captured breast cancer cells |
BREAST.CANCER__NORMAL | GSE26457 | 113 | 6 | NORMAL | - | 23057841;22025034 | Defining the Genomic Signature of the Parous Breast |
BREAST.CANCER__NORMAL | GSE7904 | 62 | 18 | NORMAL | - | 16473279 | Expression data from human breast tissue |
BREAST.CANCER__NORMAL | GSE42568 | 121 | 17 | NORMAL | - | 23740839 | Breast Cancer Gene Expression Analysis |
BREAST.CANCER__NORMAL | GSE7307 | 677 | 9 | NORMAL | - | - | Human body index - transcriptional profiling |
BREAST.CANCER__NORMAL | GSE65194 | 178 | 11 | NORMAL | - | 25848952;23700430;23144294 | Expression profiling of breast cancer samples from Institut Curie (Maire cohort) --Affy CDF |
BREAST.CANCER__NORMAL | GSE22544 | 20 | 4 | NORMAL | O | 20799942 | Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast: expression analysis |
BREAST.CANCER__NORMAL | GSE30010 | 107 | 107 | NORMAL | - | - | Expression data from breast samples of postmenopausal women |
BREAST.CANCER__NORMAL | GSE43346 | 70 | 1 | NORMAL | - | 23714854 | Gene repression with H3K27me3 modification in human small cell lung cancer |
BREAST.CANCER__NORMAL | GSE10810 | 58 | 27 | NORMAL | - | 20029976 | Gene expression signatures in breast cancer distinguish phenotype charact., histological subtypes, and tumor invasivness |
BREAST.CANCER__NORMAL | GSE31192 | 33 | 13 | NORMAL | O | 23479404 | Molecular Signature of Pregnancy Associated Breast Cancer (PABC) |
BREAST.CANCER__NORMAL | GSE5764 | 30 | 20 | NORMAL | - | 17389037 | Analysis of microdissected invasive lobular and ductal breast carcinomas in relation to normal ductal and lobular cells |
BREAST.CANCER__NORMAL | GSE10780 | 185 | 143 | NORMAL | - | 19266279 | Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue |
BREAST.CANCER__NORMAL | E-TABM-276 | 62 | 13 | NORMAL | O | 18339859 | Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes |
BREAST.CANCER__NORMAL | GSE50567 | 41 | 6 | NORMAL | - | 21196292 | BRCA1-related gene signature in breast cancer: the role of ER status and molecular type |
COLON.CANCER__CANCER-LIKE | GSE10714 | 33 | 16 | CANCER-LIKE | | 18843029;20087348 | Expression data from human colonic biopsy sample |
COLON.CANCER__CANCER-LIKE | GSE15960 | 18 | 6 | CANCER-LIKE | | 20087348 | Expression data from human colonic epithelial cells normal (N), adenoma (AD) or colorectal cancer (CRC) tissues |
COLON.CANCER__CANCER-LIKE | GSE37364 | 94 | 29 | CANCER-LIKE | | 25405986 | Expression data from human colonic biopsy samples (adenoma-carcinoma) |
COLON.CANCER__CANCER-LIKE | GSE47908 | 60 | 6 | CANCER-LIKE | | - | Transcriptional analysis of left-sided colitis, pancolitis and ulcerative colitis-associated dysplasia |
COLON.CANCER__CANCER-LIKE | GSE8671 | 64 | 24 | CANCER-LIKE | | 18171984 | Transcriptome profile of human colorectal adenomas. |
COLON.CANCER__CANCER | GSE18462 | 8 | 4 | CANCER | | - | Comparison of gene expression profiles between paired primary and metastasis colorectal carcinoma |
COLON.CANCER__CANCER | GSE10714 | 33 | 7 | CANCER | | 18843029;20087348 | Expression data from human colonic biopsy sample |
COLON.CANCER__CANCER | GSE26682 | 331 | 176 | CANCER | | 21300766;21976543;25342389 | MRE11 Deficiency Increases Sensitivity to Poly(ADP-ribose) Polymerase Inhibition in Microsatellite Unstable Colorectal Cancers. |
COLON.CANCER__CANCER | GSE41328 | 20 | 10 | CANCER | | 17160039 | Colorectal adenocarcinomas and matched normal colonic tissues |
COLON.CANCER__CANCER | GSE38832 | 122 | 60 | CANCER | | 25320007 | NFAT transcriptional activity is associated with metastatic capacity in colon cancer |
COLON.CANCER__CANCER | GSE28702 | 83 | 33 | CANCER | | 22095227 | CRC samples for FOLFOX therapy prediction |
COLON.CANCER__CANCER | GSE40367 | 61 | 14 | CANCER | | 25552933 | Gene expression analysis of liver and colon cancer primary tumors and metastasis |
COLON.CANCER__CANCER | GSE14333 | 290 | 87 | CANCER | | 19996206 | Expression data from 290 primary colorectal cancers |
COLON.CANCER__CANCER | GSE30540 | 35 | 35 | CANCER | | 22547595 | A new classification of chromosome instability (CIN) phenotype, CIN-high and CIN-low |
COLON.CANCER__CANCER | GSE20916 | 145 | 86 | CANCER | | 20957034 | Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data |
COLON.CANCER__CANCER | GSE33113 | 96 | 90 | CANCER | | 22056143;22496204 | AMC colon cancer AJCCII |
COLON.CANCER__CANCER | GSE39582 | 585 | 566 | CANCER | | 23700391 | Gene expression Classification of Colon Cancer defines six molecular subtypes with distinct clinical, molecular and survival characteristics [Expression] |
COLON.CANCER__CANCER | GSE15960 | 18 | 6 | CANCER | | 20087348 | Expression data from human colonic epithelial cells normal (N), adenoma (AD) or colorectal cancer (CRC) tissues |
COLON.CANCER__CANCER | GSE39084 | 70 | 9 | CANCER | | 25083765 | Sporadic early-onset colorectal carcinoma is a distinct clinicopathological and molecular entity |
COLON.CANCER__CANCER | GSE13294 | 155 | 155 | CANCER | | 19088021 | Expression data from primary colorectal cancers |
COLON.CANCER__CANCER | GSE17537 | 55 | 2 | CANCER | | 19914252;22115830 | Metastasis Gene Expression Profile Predicts Recurrence and Death in Colon Cancer Patients (VMC Samples) |
COLON.CANCER__CANCER | GSE17536 | 177 | 114 | CANCER | | 19914252;22115830 | Metastasis Gene Expression Profile Predicts Recurrence and Death in Colon Cancer Patients (Moffitt Samples) |
COLON.CANCER__CANCER | GSE18088 | 53 | 53 | CANCER | | 21465190 | Correlation of molecular profiles and clinical outcome of stage UICC II colon cancer patients |
COLON.CANCER__CANCER | GSE10961 | 18 | 18 | CANCER | | 18827815 | Gene expression profiling of liver metastases from colorectal cancer |
COLON.CANCER__CANCER | GSE23878 | 59 | 35 | CANCER | | 21281787 | Genome Wide Expression Analysis of Middle Eastern Colorectal Cancer Reveals FOXM1 as a Novel Target for Cancer Therapy |
COLON.CANCER__CANCER | GSE32323 | 44 | 17 | CANCER | | 22399497 | Screening for Epigenetically Masked Genes in Colorectal Cancer using 5-aza-2’-deoxycytidine treatment, Microarray and Gene Expression Profile |
COLON.CANCER__CANCER | GSE37892 | 130 | 13 | CANCER | | - | A seven-gene signature aggregates a subgroup of stage II colon cancers with stage III. |
COLON.CANCER__CANCER | GSE34489 | 33 | 33 | CANCER | | 22547595 | A new classification of chromosome instability (CIN) phynotype, CIN-high and CIN-low (validation dataset) |
COLON.CANCER__CANCER | GSE35144 | 64 | 27 | CANCER | | 22675560 | Molecular Evaluation of Patient-Derived Colorectal Cancer Explants as a Pre-clinical Mouse Model of Colorectal Cancer |
COLON.CANCER__CANCER | GSE29621 | 65 | 65 | CANCER | | 22362069 | mRNA and microRNA profile in colon cancer [mRNA data] |
COLON.CANCER__CANCER | GSE21510 | 148 | 2 | CANCER | | 21270110 | Clinical Significance of Osteoprotegerin Expression in Human Colorectal Cancer |
COLON.CANCER__CANCER | GSE27854 | 115 | 40 | CANCER | | 23065711 | Overexpression of NUCKS1 in colorectal cancer correlates with recurrence after curative surgery (gene expression analysis) |
COLON.CANCER__CANCER | GSE37364 | 94 | 27 | CANCER | | 25405986 | Expression data from human colonic biopsy samples (adenoma-carcinoma) |
COLON.CANCER__CANCER | GSE35896 | 62 | 62 | CANCER | | 23272949 | Gene expression data from 62 colorectal cancers |
COLON.CANCER__CANCER | GSE9348 | 82 | 70 | CANCER | | 20143136 | Expression data from healthy controls and early stage CRC patient's tumor |
COLON.CANCER__CANCER | GSE27157 | 10 | 10 | CANCER | | 22276141 | Prognostic Significance and Gene Expression Profiles of p53 Mutations in Microsatellite Stable Stage III Colorectal Adenocarcinoma |
COLON.CANCER__CANCER | GSE19860 | 40 | 19 | CANCER | | - | Prediction of response to FOLFOX |
COLON.CANCER__CANCER | GSE31595 | 37 | 37 | CANCER | | - | Gene Expression Profiles in Stage II and III Colon Cancer. Application of a 128-gene signature |
COLON.CANCER__CANCER | GSE13471 | 18 | 4 | CANCER | | 19151715 | Expression data from human normal pre-frontal cortex, liver, and colon tissues and colon tumors |
COLON.CANCER__CANCER | GSE4107 | 22 | 12 | CANCER | | 17317818 | Expression profiling in early onset colorectal cancer |
COLON.CANCER__CANCER | GSE13067 | 74 | 28 | CANCER | | 19088021 | Expression data from primary colorectal cancers |
COLON.CANCER__CANCER | GSE9452 | 26 | 1 | CANCER | | 19177426 | Definition of an ulcerative colitis preinflammatory state |
COLON.CANCER__NORMAL | GSE18462 | 8 | 2 | NORMAL | - | - | Comparison of gene expression profiles between paired primary and metastasis colorectal carcinoma |
COLON.CANCER__NORMAL | GSE10714 | 33 | 3 | NORMAL | - | 18843029;20087348 | Expression data from human colonic biopsy sample |
COLON.CANCER__NORMAL | GSE9254 | 19 | 12 | NORMAL | - | 18056783 | Normal human colorectal mucosa, cecum, ascending, transverse, sigmoid and rectum |
COLON.CANCER__NORMAL | GSE41328 | 20 | 10 | NORMAL | - | 17160039 | Colorectal adenocarcinomas and matched normal colonic tissues |
COLON.CANCER__NORMAL | GSE32323 | 44 | 17 | NORMAL | - | 22399497 | Screening for Epigenetically Masked Genes in Colorectal Cancer using 5-aza-2’-deoxycytidine treatment, Microarray and Gene Expression Profile |
COLON.CANCER__NORMAL | GSE36807 | 35 | 7 | NORMAL | - | 24155895 | Genome-wide analysis of Crohn's disease and ulcerative colitis biopsy samples. |
COLON.CANCER__NORMAL | GSE11831 | 17 | 17 | NORMAL | - | 16959948;19603079;19177426 | Transcription profiling of biopsies from the descending colon of control subjects |
COLON.CANCER__NORMAL | GSE43346 | 70 | 1 | NORMAL | - | 23714854 | Gene repression with H3K27me3 modification in human small cell lung cancer |
COLON.CANCER__NORMAL | GSE20916 | 145 | 37 | NORMAL | - | 20957034 | Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data |
COLON.CANCER__NORMAL | GSE10791 | 2 | 1 | NORMAL | - | 18835392 | Gene expression profiles in sigmoid colon biopsies from healthy and patients with ulcerative colitis |
COLON.CANCER__NORMAL | GSE47908 | 60 | 15 | NORMAL | - | - | Transcriptional analysis of left-sided colitis, pancolitis and ulcerative colitis-associated dysplasia |
COLON.CANCER__NORMAL | GSE33113 | 96 | 6 | NORMAL | - | 22056143;22496204 | AMC colon cancer AJCCII |
COLON.CANCER__NORMAL | GSE15960 | 18 | 6 | NORMAL | - | 20087348 | Expression data from human colonic epithelial cells normal (N), adenoma (AD) or colorectal cancer (CRC) tissues |
COLON.CANCER__NORMAL | GSE8671 | 64 | 25 | NORMAL | O | 18171984 | Transcriptome profile of human colorectal adenomas. |
COLON.CANCER__NORMAL | GSE7307 | 677 | 4 | NORMAL | - | - | Human body index - transcriptional profiling |
COLON.CANCER__NORMAL | GSE23878 | 59 | 24 | NORMAL | - | 21281787 | Genome Wide Expression Analysis of Middle Eastern Colorectal Cancer Reveals FOXM1 as a Novel Target for Cancer Therapy |
COLON.CANCER__NORMAL | GSE36701 | 221 | 77 | NORMAL | - | 22684480 | Gene expression analysis of rectal mucosa in chronic irritable bowel syndrome (IBS) compared to healthy volunteers (HV) |
COLON.CANCER__NORMAL | GSE21510 | 148 | 24 | NORMAL | - | 21270110 | Clinical Significance of Osteoprotegerin Expression in Human Colorectal Cancer |
COLON.CANCER__NORMAL | GSE22619 | 20 | 10 | NORMAL | - | 21621540;22826509 | Genome wide expression data from discordant twins (ulcerative colitis, primary mucosal tissue) |
COLON.CANCER__NORMAL | GSE37364 | 94 | 38 | NORMAL | - | 25405986 | Expression data from human colonic biopsy samples (adenoma-carcinoma) |
COLON.CANCER__NORMAL | GSE37267 | 6 | 6 | NORMAL | - | - | Expression data from human colonic biopsy samples |
COLON.CANCER__NORMAL | GSE13367 | 56 | 19 | NORMAL | O | 19834973 | Genome-wide gene expression analysis of mucosal colonic biopsies and isolated colonocytes... |
COLON.CANCER__NORMAL | GSE9348 | 82 | 12 | NORMAL | - | 20143136 | Expression data from healthy controls and early stage CRC patient's tumor |
COLON.CANCER__NORMAL | GSE16879 | 133 | 6 | NORMAL | O | 19956723 | Mucosal expression profiling in patients with inflammatory bowel disease before and after first infliximab treatment |
COLON.CANCER__NORMAL | GSE19963 | 9 | 4 | NORMAL | - | - | Expression data from hyperplastic polyps and normal colonic mucosa from patients with familial and sporadic HPPS |
COLON.CANCER__NORMAL | GSE9452 | 26 | 2 | NORMAL | O | 19177426 | Definition of an ulcerative colitis preinflammatory state |
COLON.CANCER__NORMAL | GSE13471 | 18 | 4 | NORMAL | - | 19151715 | Expression data from human normal pre-frontal cortex, liver, and colon tissues and colon tumors |
COLON.CANCER__NORMAL | GSE4107 | 22 | 10 | NORMAL | - | 17317818 | Expression profiling in early onset colorectal cancer |
COLON.CANCER__NORMAL | GSE38713 | 43 | 13 | NORMAL | - | 23135761 | Expression data from intestinal mucosa of patients with UC |
COLON.CANCER__NORMAL | E-TABM-176 | 132 | 55 | NORMAL | O | - | Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects |
ESOPHAGAL.CANCER__CANCER-LIKE | GSE26886 | 69 | 18 | CANCER-LIKE | | 23514407 | Gene expression profiling of Barrett's esophagus, adenocarcinoma, esophageal squamous epithelium and squamous cell carcinoma |
ESOPHAGAL.CANCER__CANCER | GSE33810 | 3 | 2 | CANCER | | 23894350 | Expression data of tumor and non-tumor samples from patients with esophageal cancer |
ESOPHAGAL.CANCER__CANCER | GSE42363 | 14 | 14 | CANCER | | 23525077 | Exome and whole genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity |
ESOPHAGAL.CANCER__CANCER | GSE26886 | 69 | 30 | CANCER | | 23514407 | Gene expression profiling of Barrett's esophagus, adenocarcinoma, esophageal squamous epithelium and squamous cell carcinoma |
ESOPHAGAL.CANCER__CANCER | GSE17351 | 10 | 5 | CANCER | | - | Expression data from esophageal squamous cell carcinoma (ESCC) |
ESOPHAGAL.CANCER__CANCER | GSE32701 | 40 | 40 | CANCER | | 21533028 | Individual aiEMT in surgical samples of esophageal cancer patients |
ESOPHAGAL.CANCER__NORMAL | GSE17351 | 10 | 5 | NORMAL | - | - | Expression data from esophageal squamous cell carcinoma (ESCC) |
ESOPHAGAL.CANCER__NORMAL | GSE33810 | 3 | 1 | NORMAL | - | 23894350 | Expression data of tumor and non-tumor samples from patients with esophageal cancer |
ESOPHAGAL.CANCER__NORMAL | GSE7307 | 677 | 3 | NORMAL | - | - | Human body index - transcriptional profiling |
ESOPHAGAL.CANCER__NORMAL | GSE43346 | 70 | 1 | NORMAL | - | 23714854 | Gene repression with H3K27me3 modification in human small cell lung cancer |
GASTRIC.CANCER__CANCER | GSE22377 | 43 | 43 | CANCER | | 21701537 | mRNA expression data from human adenocarcinomas of the stomach |
GASTRIC.CANCER__CANCER | GSE35809 | 70 | 1 | CANCER | | 22735568 | Gastric Cancer Subtyping (Australian Patient Cohort) |
GASTRIC.CANCER__CANCER | GSE17187 | 6 | 6 | CANCER | | 20386750 | Gene expression analysis of 3 node positive vs 3 node negative intestinal type gastric cancers by gene array technology. |
GASTRIC.CANCER__CANCER | GSE20708 | 22 | 19 | CANCER | | 20548289 | Gene expression data from GIST with KIT mutation |
GASTRIC.CANCER__CANCER | GSE28702 | 83 | 3 | CANCER | | 22095227 | CRC samples for FOLFOX therapy prediction |
GASTRIC.CANCER__CANCER | GSE40367 | 61 | 1 | CANCER | | 25552933 | Gene expression analysis of liver and colon cancer primary tumors and metastasis |
GASTRIC.CANCER__CANCER | GSE38749 | 15 | 15 | CANCER | | - | Expression data of Human Gastric Adenocarcinoma |
GASTRIC.CANCER__CANCER | GSE51105 | 94 | 94 | CANCER | | 24658156 | A signature predicting poor prognosis in gastric and ovarian cancer represents a coordinated macrophage and stromal-response. |
GASTRIC.CANCER__CANCER | GSE34942 | 56 | 56 | CANCER | | 25053715;23684942 | Gastric cancer subtyping (Singapore Patient Cohort, batch B) |
GASTRIC.CANCER__CANCER | GSE17743 | 29 | 29 | CANCER | | 19943934 | Gene expression profiles differentiating gastrointestinal stromal tumours according to KIT mutations and expression |
GASTRIC.CANCER__CANCER | GSE62254 | 300 | 300 | CANCER | | 25894828 | Molecular analysis of gastric cancer identifies discrete subtypes associated with distinct clinical characteristics and survival outcomes: the ACRG (Asian Cancer Research Group) study [gastric tumors] |
GASTRIC.CANCER__CANCER | GSE15459 | 200 | 200 | CANCER | | 19798449;21471434 | Gastric Cancer Project '08 (Singapore Patient Cohort) |
GASTRIC.CANCER__CANCER | GSE19826 | 27 | 12 | CANCER | | 21132402 | Expression data from gastric cancer |
GASTRIC.CANCER__CANCER | GSE8167 | 32 | 31 | CANCER | | 18757323 | Distinct gene-expression-defined classes of gastrointestinal stromal tumor (GIST). |
GASTRIC.CANCER__CANCER | GSE57303 | 70 | 70 | CANCER | | 24935174 | Expression data from 70 gastric cancer patients |
GASTRIC.CANCER__CANCER | GSE13911 | 69 | 38 | CANCER | | 19081245 | Expression data from primary gastric tumors (MSI and MSS) and adjacent normal samples |
GASTRIC.CANCER__NORMAL | GSE7307 | 677 | 12 | NORMAL | - | - | Human body index - transcriptional profiling |
GASTRIC.CANCER__NORMAL | GSE7821 | 40 | 40 | NORMAL | - | 19276242;21621540 | Expression data from human intestinal biopsies |
GASTRIC.CANCER__NORMAL | GSE43346 | 70 | 1 | NORMAL | - | 23714854 | Gene repression with H3K27me3 modification in human small cell lung cancer |
GASTRIC.CANCER__NORMAL | GSE19826 | 27 | 15 | NORMAL | O | 21132402 | Expression data from gastric cancer |
GASTRIC.CANCER__NORMAL | GSE13911 | 69 | 31 | NORMAL | - | 19081245 | Expression data from primary gastric tumors (MSI and MSS) and adjacent normal samples |
HEAD.AND.NECK.CANCER__CANCER-LIKE | GSE30784 | 229 | 16 | CANCER-LIKE | | 18669583 | Gene expression profiling of oral squamous cell carcinoma (OSCC) |
HEAD.AND.NECK.CANCER__CANCER | GSE10300 | 44 | 23 | CANCER | | 19117988 | head and neck squamous cell carcinoma samples |
HEAD.AND.NECK.CANCER__CANCER | GSE30784 | 229 | 167 | CANCER | | 18669583 | Gene expression profiling of oral squamous cell carcinoma (OSCC) |
HEAD.AND.NECK.CANCER__CANCER | GSE3292 | 36 | 21 | CANCER | | 16467079;16943533 | Gene expression signature of HPV in head and neck squamous cell carcinoma |
HEAD.AND.NECK.CANCER__CANCER | GSE34573 | 64 | 15 | CANCER | | 22815911 | A Global View of the Oncogenic Landscape in Nasopharyngeal Carcinoma:An Integrated Analysis at the Genetic and Expression Levels |
HEAD.AND.NECK.CANCER__CANCER | E-TABM-302 | 82 | 70 | CANCER | | 18679425 | Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers |
HEAD.AND.NECK.CANCER__CANCER | GSE12452 | 41 | 31 | CANCER | | 17119049;16912175;22880099 | mRNA expression profiling of nasopharyngeal carcinoma |
HEAD.AND.NECK.CANCER__CANCER | GSE6791 | 84 | 17 | CANCER | | 17510386 | Gene Expression Profiles of HPV-Positive and -Negative Head/Neck and Cervical Cancers |
HEAD.AND.NECK.CANCER__NORMAL | GSE7307 | 677 | 6 | NORMAL | - | - | Human body index - transcriptional profiling |
HEAD.AND.NECK.CANCER__NORMAL | GSE34573 | 64 | 4 | NORMAL | - | 22815911 | A Global View of the Oncogenic Landscape in Nasopharyngeal Carcinoma:An Integrated Analysis at the Genetic and Expression Levels |
HEAD.AND.NECK.CANCER__NORMAL | GSE30784 | 229 | 45 | NORMAL | - | 18669583 | Gene expression profiling of oral squamous cell carcinoma (OSCC) |
HEAD.AND.NECK.CANCER__NORMAL | GSE3526 | 353 | 4 | NORMAL | - | 16572319 | Comparison of gene expression profiles across the normal human body |
HEAD.AND.NECK.CANCER__NORMAL | GSE13933 | 87 | 42 | NORMAL | - | 20443905 | Trachea Epithelium as a “ Canary” for Cigarette Smoking-induced Biologic Phenotype of Small Airway Epithelium |
HEAD.AND.NECK.CANCER__NORMAL | GSE12452 | 41 | 10 | NORMAL | O | 17119049;16912175;22880099 | mRNA expression profiling of nasopharyngeal carcinoma |
HEAD.AND.NECK.CANCER__NORMAL | GSE43346 | 70 | 2 | NORMAL | - | 23714854 | Gene repression with H3K27me3 modification in human small cell lung cancer |
HEAD.AND.NECK.CANCER__NORMAL | GSE6791 | 84 | 4 | NORMAL | - | 17510386 | Gene Expression Profiles of HPV-Positive and -Negative Head/Neck and Cervical Cancers |
HEART.CANCER__NORMAL | GSE3526 | 353 | 11 | NORMAL | - | 16572319 | Comparison of gene expression profiles across the normal human body |
LIVER.CANCER__CANCER-LIKE | GSE6764 | 75 | 16 | CANCER-LIKE | | 17393520 | Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma |
LIVER.CANCER__CANCER | GSE6465 | 53 | 7 | CANCER | | 18490075 | Expression data of Hepatocellular Carcinoma |
LIVER.CANCER__CANCER | GSE41804 | 40 | 20 | CANCER | | 23426277 | Hepatic gene expression of HCV related Hepatocellular carcinoma and non-cancerous tissue with Il28B rs8099917 TT genotype and TG/GG genotype |
LIVER.CANCER__CANCER | GSE62232 | 91 | 81 | CANCER | | - | Large-scale gene expression profiling of 81 hepatocellular carcinomas |
LIVER.CANCER__CANCER | GSE6764 | 75 | 13 | CANCER | | 17393520 | Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma |
LIVER.CANCER__CANCER | GSE17548 | 37 | 17 | CANCER | | 23691139 | Expression data from cirrhosis and HCC tissue samples |
LIVER.CANCER__CANCER | GSE19665 | 20 | 10 | CANCER | | 20345479 | Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma |
LIVER.CANCER__CANCER | GSE6222 | 13 | 10 | CANCER | | 18504433 | Genome-wide analysis of gene expression patterns in human liver cancers |
LIVER.CANCER__CANCER | E-MTAB-1503 | 40 | 29 | CANCER | | - | Transcription profiling by array of Pure Fibrolamellar Hepatocellular carcinoma |
LIVER.CANCER__CANCER | GSE29721 | 20 | 10 | CANCER | | 21747116 | The landscape of promoter DNA hypomethylation in liver cancer (expression data) |
LIVER.CANCER__CANCER | GSE33006 | 6 | 3 | CANCER | | 22923518 | Gene expression profiles from the hepatocellular carcinoma (HCC) tissues |
LIVER.CANCER__CANCER | GSE55092 | 140 | 49 | CANCER | | 25141867 | Viral Expression and Molecular Profiling in Liver Tissue versus Microdissected Hepatocytes in Hepatitis B Virus - Associated Hepatocellular Carcinoma |
LIVER.CANCER__CANCER | GSE40367 | 61 | 32 | CANCER | | 25552933 | Gene expression analysis of liver and colon cancer primary tumors and metastasis |
LIVER.CANCER__CANCER | GSE9843 | 91 | 90 | CANCER | | 18701503;21320499;21324318 | Gene expression profiling of 91 hepatocellular carcinomas with hepatitis C virus etiology |
LIVER.CANCER__CANCER | GSE45267 | 87 | 32 | CANCER | | - | Gene expression profiles of human hepatocellular carcinoma (training set 1) |
LIVER.CANCER__CANCER | GSE28702 | 83 | 23 | CANCER | | 22095227 | CRC samples for FOLFOX therapy prediction |
LIVER.CANCER__CANCER | E-MTAB-950 | 281 | 11 | CANCER | | - | Transcription profiling by array of human normal liver, HBV, HCV and haemochromatosis background cirrhotic and hematocellular carcinoma liver samples. |
LIVER.CANCER__NORMAL | GSE18462 | 8 | 2 | NORMAL | - | - | Comparison of gene expression profiles between paired primary and metastasis colorectal carcinoma |
LIVER.CANCER__NORMAL | GSE41804 | 40 | 20 | NORMAL | O | 23426277 | Hepatic gene expression of HCV related Hepatocellular carcinoma and non-cancerous tissue with Il28B rs8099917 TT genotype and TG/GG genotype |
LIVER.CANCER__NORMAL | GSE62232 | 91 | 10 | NORMAL | - | - | Large-scale gene expression profiling of 81 hepatocellular carcinomas |
LIVER.CANCER__NORMAL | GSE15239 | 12 | 6 | NORMAL | - | - | Expression data from human livers shortly following partial hepatectomy (PHx) |
LIVER.CANCER__NORMAL | GSE24042 | 2 | 2 | NORMAL | - | - | Adult human liver tissue expression (Affymetrix) |
LIVER.CANCER__NORMAL | GSE43346 | 70 | 1 | NORMAL | - | 23714854 | Gene repression with H3K27me3 modification in human small cell lung cancer |
LIVER.CANCER__NORMAL | GSE45267 | 87 | 39 | NORMAL | - | - | Gene expression profiles of human hepatocellular carcinoma (training set 1) |
LIVER.CANCER__NORMAL | GSE38597 | 8 | 2 | NORMAL | - | 22677194 | Gene expression profiling of 6 acute hepatitis C patients |
LIVER.CANCER__NORMAL | GSE29721 | 20 | 10 | NORMAL | - | 21747116 | The landscape of promoter DNA hypomethylation in liver cancer (expression data) |
LIVER.CANCER__NORMAL | GSE7307 | 677 | 4 | NORMAL | - | - | Human body index - transcriptional profiling |
LIVER.CANCER__NORMAL | GSE40873 | 49 | 49 | NORMAL | - | 23543312 | Low SLC22A7 expression in noncancerous liver promotes hepatocellular carcinoma occurrence - a prospective study |
LIVER.CANCER__NORMAL | GSE7117 | 8 | 4 | NORMAL | - | 18804985 | Hepatic gene expression after a hypocaloric, low-fat diet in obese women and controls |
LIVER.CANCER__NORMAL | GSE38941 | 27 | 10 | NORMAL | - | 23185381 | Liver Regeneration Gene Signature in Hepatitis B virus (HBV)-Associated Acute Liver Failure Identified by Gene Expression Profiling |
LIVER.CANCER__NORMAL | E-MTAB-950 | 281 | 4 | NORMAL | - | - | Transcription profiling by array of human normal liver, HBV, HCV and haemochromatosis background cirrhotic and hematocellular carcinoma liver samples. |
LIVER.CANCER__NORMAL | GSE6764 | 75 | 10 | NORMAL | - | 17393520 | Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma |
LIVER.CANCER__NORMAL | GSE19665 | 20 | 10 | NORMAL | O | 20345479 | Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma |
LIVER.CANCER__NORMAL | GSE23343 | 17 | 7 | NORMAL | - | 21035759 | Expression data from human liver with or without type 2 diabetes |
LIVER.CANCER__NORMAL | GSE3526 | 353 | 3 | NORMAL | - | 16572319 | Comparison of gene expression profiles across the normal human body |
LIVER.CANCER__NORMAL | GSE33006 | 6 | 3 | NORMAL | O | 22923518 | Gene expression profiles from the hepatocellular carcinoma (HCC) tissues |
LIVER.CANCER__NORMAL | GSE55092 | 140 | 91 | NORMAL | O | 25141867 | Viral Expression and Molecular Profiling in Liver Tissue versus Microdissected Hepatocytes in Hepatitis B Virus - Associated Hepatocellular Carcinoma |
LIVER.CANCER__NORMAL | GSE6222 | 13 | 2 | NORMAL | - | 18504433 | Genome-wide analysis of gene expression patterns in human liver cancers |
LIVER.CANCER__NORMAL | GSE13471 | 18 | 5 | NORMAL | - | 19151715 | Expression data from human normal pre-frontal cortex, liver, and colon tissues and colon tumors |
LIVER.CANCER__NORMAL | E-MTAB-1503 | 40 | 10 | NORMAL | - | - | Transcription profiling by array of Pure Fibrolamellar Hepatocellular carcinoma |
LUNG.CANCER__CANCER | GSE31210 | 246 | 226 | CANCER | | 22080568;23028479 | Gene expression data for pathological stage I-II lung adenocarcinomas |
LUNG.CANCER__CANCER | GSE28702 | 83 | 1 | CANCER | | 22095227 | CRC samples for FOLFOX therapy prediction |
LUNG.CANCER__CANCER | GSE40791 | 194 | 94 | CANCER | | 23187126 | Usp44 binds centrin to regulate centrosome positioning and suppress tumorigenesis |
LUNG.CANCER__CANCER | GSE10799 | 19 | 16 | CANCER | | 19208797 | Gene expression profile of lung tumors |
LUNG.CANCER__CANCER | GSE19188 | 156 | 91 | CANCER | | 20421987 | Expression data for early stage NSCLC |
LUNG.CANCER__CANCER | GSE33532 | 100 | 80 | CANCER | | - | Intratumor heterogeneity of gene expression profiles in early stage non-small cell lung cancer (NSCLC) |
LUNG.CANCER__CANCER | GSE43346 | 70 | 23 | CANCER | | 23714854 | Gene repression with H3K27me3 modification in human small cell lung cancer |
LUNG.CANCER__CANCER | GSE27716 | 40 | 40 | CANCER | | 21911454 | Expression data from Columbia Lung Adenocarcinoma Human Tumor Cells |
LUNG.CANCER__CANCER | GSE63074 | 410 | 376 | CANCER | | - | Expression data from non-small cell lung carcinoma (NSCLC) |
LUNG.CANCER__CANCER | GSE43580 | 150 | 150 | CANCER | | 23966112 | SBV - Gene Expression Profiles of Lung Cancer Tumors - Adenocarcinomas and Squamous Cell Carcinomas |
LUNG.CANCER__CANCER | GSE12667 | 75 | 75 | CANCER | | 18948947 | Discovery of somatic mutations in lung adenocarcinomas |
LUNG.CANCER__CANCER | GSE50081 | 181 | 181 | CANCER | | 24305008 | Validation of a histology-independent prognostic gene signature for early stage, non-small cell lung cancer including stage IA patients |
LUNG.CANCER__CANCER | GSE8581 | 58 | 57 | CANCER | | 18849563 | Human Chronic Obstructive Pulmonary Disorder (COPD) Biomarker |
LUNG.CANCER__CANCER | GSE31546 | 17 | 17 | CANCER | | - | UMCCC Primary Lung Cancer Specimens |
LUNG.CANCER__CANCER | GSE10445 | 72 | 72 | CANCER | | 19176396;20810387 | MERLION LUNG CANCER STUDY |
LUNG.CANCER__CANCER | GSE27262 | 50 | 25 | CANCER | | 22726390 | Gene expression profiling of Non-small cell lung cancer in Taiwan |
LUNG.CANCER__CANCER | GSE33363 | 10 | 5 | CANCER | | 22392539 | CD99 is a novel prognostic stromal marker in non-small cell lung cancer |
LUNG.CANCER__CANCER | E-MTAB-2435 | 95 | 7 | CANCER | | - | LSCC |
LUNG.CANCER__CANCER | GSE18842 | 91 | 91 | CANCER | | 20878980 | Gene expression analysis of human lung cancer and control samples |
LUNG.CANCER__CANCER | GSE19804 | 120 | 60 | CANCER | | 20802022 | Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan |
LUNG.CANCER__CANCER | GSE29013 | 55 | 55 | CANCER | | 21742808 | Robust Gene Expression Signature from Formalin-Fixed Paraffin-Embedded Samples Predicts Prognosis of Non-Small-Cell Lung Cancer Patients |
LUNG.CANCER__CANCER | GSE14108 | 28 | 19 | CANCER | | - | Brain metastasis from lung adenocarcinoma patients |
LUNG.CANCER__CANCER | GSE37745 | 196 | 196 | CANCER | | 23032747 | Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis and tissue microarray validation |
LUNG.CANCER__CANCER | GSE35679 | 13 | 13 | CANCER | | - | lung carcinoid |
LUNG.CANCER__CANCER | GSE10245 | 58 | 58 | CANCER | | 18486272 | Gene expression differences between adenocarcinoma and squamous cell carcinoma in human NSCLC |
LUNG.CANCER__NORMAL | GSE5058 | 39 | 24 | NORMAL | - | 17108109;19106307 | Airway epithelium, small airways, normal non-smokers, phenotypic normal smokers, smokers with COPD and early COPD |
LUNG.CANCER__NORMAL | E-MTAB-1727 | 174 | 16 | NORMAL | - | - | CIT_BRON-LBAN-LUTN_109s_EXP_SNP |
LUNG.CANCER__NORMAL | GSE4302 | 118 | 28 | NORMAL | - | 17898169 | Genome-Wide Profiling of Airway Epithelial Cells in Asthmatics, Smokers and Healthy Controls |
LUNG.CANCER__NORMAL | GSE16538 | 12 | 6 | NORMAL | - | 19218196 | Genome-wide gene expression profile analysis in pulmonary sarcoidosis |
LUNG.CANCER__NORMAL | GSE31210 | 246 | 20 | NORMAL | - | 22080568;23028479 | Gene expression data for pathological stage I-II lung adenocarcinomas |
LUNG.CANCER__NORMAL | GSE14334 | 38 | 36 | NORMAL | - | 19815808;24929828 | Transcriptomic analysis of human lung development |
LUNG.CANCER__NORMAL | GSE40791 | 194 | 100 | NORMAL | - | 23187126 | Usp44 binds centrin to regulate centrosome positioning and suppress tumorigenesis |
LUNG.CANCER__NORMAL | GSE10799 | 19 | 3 | NORMAL | - | 19208797 | Gene expression profile of lung tumors |
LUNG.CANCER__NORMAL | GSE19188 | 156 | 65 | NORMAL | - | 20421987 | Expression data for early stage NSCLC |
LUNG.CANCER__NORMAL | GSE43346 | 70 | 2 | NORMAL | - | 23714854 | Gene repression with H3K27me3 modification in human small cell lung cancer |
LUNG.CANCER__NORMAL | GSE19407 | 127 | 37 | NORMAL | - | 21490961 | Smoking-induced Wnt pathway downregulation |
LUNG.CANCER__NORMAL | GSE21369 | 29 | 5 | NORMAL | - | 21241464 | Gene expression profiles of interstitial lung disease (ILD) patients |
LUNG.CANCER__NORMAL | GSE24206 | 23 | 6 | NORMAL | - | 21974901 | Validated Gene Expression Signatures of Idiopathic Pulmonary Fibrosis |
LUNG.CANCER__NORMAL | GSE7307 | 677 | 6 | NORMAL | - | - | Human body index - transcriptional profiling |
LUNG.CANCER__NORMAL | GSE13933 | 87 | 14 | NORMAL | - | 20443905 | Trachea Epithelium as a “ Canary” for Cigarette Smoking-induced Biologic Phenotype of Small Airway Epithelium |
LUNG.CANCER__NORMAL | GSE10006 | 87 | 13 | NORMAL | - | 18832735 | Decreased Expression of Intelectin 1 in The Human Airway Epithelium of Smokers Compared to Nonsmokers |
LUNG.CANCER__NORMAL | GSE27262 | 50 | 25 | NORMAL | O | 22726390 | Gene expression profiling of Non-small cell lung cancer in Taiwan |
LUNG.CANCER__NORMAL | GSE30063 | 169 | 135 | NORMAL | - | 22855713 | Epithelial Expression of Toll-like Receptor 5 is Modulated in Healthy Smokers and Smokers with Chronic Obstructive Lung Disease |
LUNG.CANCER__NORMAL | GSE33532 | 100 | 20 | NORMAL | O | - | Intratumor heterogeneity of gene expression profiles in early stage non-small cell lung cancer (NSCLC) |
LUNG.CANCER__NORMAL | GSE19804 | 120 | 60 | NORMAL | O | 20802022 | Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan |
LUNG.CANCER__NORMAL | GSE8545 | 54 | 35 | NORMAL | - | 18339782 | Variability in Small Airway Epithelial Gene Expression Among Normal Smokers |
LUNG.CANCER__NORMAL | GSE22047 | 342 | 196 | NORMAL | - | 21325429 | Modulation of Cystatin A Expression in Human Airway Epithelium Related to Genotype, Smoking COPD and Lung Cancer |
MENINGIOMA__CANCER | E-MTAB-1852 | 43 | 15 | CANCER | | - | High-through put translational in vivo and ex vivo techniques for glioma molecular characterization and accurate classification, prognosis and treatment selection subset data from etumour consorteum Kal1 |
MENINGIOMA__CANCER | GSE16581 | 68 | 68 | CANCER | | 20015288 | Genomic landscape of meningiomas: gene expression |
MENINGIOMA__CANCER | GSE9438 | 31 | 30 | CANCER | | 18172325 | Gene Expression is associated with Progesterone Receptor Status in Meningioma |
MESOTHELIOMA.TUMOR__NORMAL | GSE12345 | 13 | 3 | NORMAL | - | 19753302 | Global gene expression profiling of human pleural mesotheliomas |
NEUROECTODERMAL.TUMOR__NORMAL | GSE7307 | 677 | 8 | NORMAL | - | - | Human body index - transcriptional profiling |
ORAL.CANCER__CANCER | GSE42743 | 103 | 74 | CANCER | | 23319825 | Oral Cavity Cancer Compared to Adjacent "Normal" Tissue [Validation Set] |
ORAL.CANCER__CANCER | GSE3292 | 36 | 15 | CANCER | | 16467079;16943533 | Gene expression signature of HPV in head and neck squamous cell carcinoma |
ORAL.CANCER__CANCER | GSE6791 | 84 | 24 | CANCER | | 17510386 | Gene Expression Profiles of HPV-Positive and -Negative Head/Neck and Cervical Cancers |
ORAL.CANCER__CANCER | GSE9844 | 38 | 25 | CANCER | | 18254958 | Transcriptomic Dissection of Tongue Squamous Cell Carcinoma |
ORAL.CANCER__CANCER | E-TABM-302 | 82 | 28 | CANCER | | 18679425 | Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers |
ORAL.CANCER__CANCER | GSE41613 | 97 | 97 | CANCER | | 23319825 | A 13-gene signature prognostic of HPV-negative OSCC: discovery and external validation |
ORAL.CANCER__CANCER | GSE38494 | 35 | 12 | CANCER | | 25398365 | Expression data from odontogenic tumours |
ORAL.CANCER__NORMAL | GSE42743 | 103 | 29 | NORMAL | - | 23319825 | Oral Cavity Cancer Compared to Adjacent "Normal" Tissue [Validation Set] |
ORAL.CANCER__NORMAL | GSE7224 | 13 | 7 | NORMAL | - | 17620369 | Gene expression in tonsil and oral epithelia |
ORAL.CANCER__NORMAL | GSE7307 | 677 | 19 | NORMAL | - | - | Human body index - transcriptional profiling |
ORAL.CANCER__NORMAL | GSE6791 | 84 | 10 | NORMAL | - | 17510386 | Gene Expression Profiles of HPV-Positive and -Negative Head/Neck and Cervical Cancers |
ORAL.CANCER__NORMAL | GSE8764 | 13 | 13 | NORMAL | - | 18571147 | Age and Gender Related Changes in Human Parotid Gland Gene Expression |
ORAL.CANCER__NORMAL | GSE9844 | 38 | 11 | NORMAL | - | 18254958 | Transcriptomic Dissection of Tongue Squamous Cell Carcinoma |
ORAL.CANCER__NORMAL | GSE4250 | 4 | 2 | NORMAL | - | 17075716 | Determination of expression level of gingiva expressed genes |
ORAL.CANCER__NORMAL | GSE43346 | 70 | 2 | NORMAL | - | 23714854 | Gene repression with H3K27me3 modification in human small cell lung cancer |
ORAL.CANCER__NORMAL | GSE10334 | 247 | 64 | NORMAL | O | 18980520 | Transcriptomes in Healthy and Diseased Gingival Tissues |
OVARIAN.CANCER__CANCER-LIKE | GSE41498 | 9 | 7 | CANCER-LIKE | | 23128397 | Profiling of ovarian tumour and benign lesions |
OVARIAN.CANCER__CANCER | GSE14001 | 23 | 20 | CANCER | | 19525924 | PAX2: A Potential Biomarker for Low Malignant Potential Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas |
OVARIAN.CANCER__CANCER | GSE29450 | 20 | 10 | CANCER | | 21754983 | Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers |
OVARIAN.CANCER__CANCER | GSE26193 | 107 | 107 | CANCER | | 22101765 | Control of oxidative stress by miRNA and impact on ovarian tumorigenesis |
OVARIAN.CANCER__CANCER | GSE18520 | 63 | 15 | CANCER | | 19962670 | Whole-genome oligonucleotide expression analysis of papillary serous ovarian adenocarcinomas |
OVARIAN.CANCER__CANCER | GSE32062 | 270 | 10 | CANCER | | 22241791 | Immune-activation as a therapeutic direction for patients with high-risk ovarian cancer based on gene expression signature (1) |
OVARIAN.CANCER__CANCER | GSE9890 | 10 | 4 | CANCER | | 18698038 | Expression profile of 5 ovarian tumour samples (two different cell types from each sample profiles) |
OVARIAN.CANCER__CANCER | GSE9891 | 285 | 250 | CANCER | | 18698038 | Expression profile of 285 ovarian tumour samples |
OVARIAN.CANCER__CANCER | GSE38666 | 45 | 25 | CANCER | | 23762861 | Molecular Profiling provides evidence of the existence of two functionally distinct classes of ovarian cancer stroma |
OVARIAN.CANCER__CANCER | GSE27651 | 49 | 35 | CANCER | | 21451362 | The Anterior Gradient Homolog 3 (AGR3) Gene Is Associated with Differentiation and Survival in Ovarian Cancer |
OVARIAN.CANCER__CANCER | GSE15578 | 17 | 4 | CANCER | | - | Expression Data from Ovarian Surface Kinome |
OVARIAN.CANCER__CANCER | E-MEXP-1085 | 43 | 42 | CANCER | | - | Transcription profiling of human ovarian tumors from the MALOVA (MALignant OVArian) cancer study |
OVARIAN.CANCER__CANCER | GSE27659 | 10 | 10 | CANCER | | 20802181 | BRAF Mutation Is Rare in Advanced-Stage Low-Grade Ovarian Serous Carcinomas |
OVARIAN.CANCER__CANCER | GSE44104 | 60 | 60 | CANCER | | 23934190 | COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer. |
OVARIAN.CANCER__CANCER | GSE39204 | 64 | 64 | CANCER | | 23340297 | Gene-expression profiles of ascites-cytology-positive ovarian cancer |
OVARIAN.CANCER__CANCER | GSE63885 | 101 | 101 | CANCER | | 24478986 | Gene expression profiling in ovarian cancer |
OVARIAN.CANCER__CANCER | GSE20565 | 172 | 37 | CANCER | | 20492709 | Primary and secondary ovarian tumors |
OVARIAN.CANCER__CANCER | GSE36668 | 12 | 2 | CANCER | | 23029477 | Expression data from serous ovarian carcinomas, serous ovarian borderline tumors and surface epithelium scrapings from normal ovaries |
OVARIAN.CANCER__CANCER | GSE30161 | 58 | 58 | CANCER | | 22348014 | Genomic Multivariate Predictors of Response to Adjuvant Chemotherapy in Ovarian Carcinoma: Predicting Platinum Resistance |
OVARIAN.CANCER__CANCER | GSE19829 | 70 | 28 | CANCER | | 20547991 | A gene expression profile of BRCAness that is associated with outcome in ovarian cancer |
OVARIAN.CANCER__CANCER | GSE19352 | 28 | 20 | CANCER | | 20179205 | Activation of phosphatidylcholine-cycle enzymes in human epithelial ovarian cancer cells |
OVARIAN.CANCER__CANCER | GSE41498 | 9 | 1 | CANCER | | 23128397 | Profiling of ovarian tumour and benign lesions |
OVARIAN.CANCER__CANCER | E-MEXP-935 | 28 | 27 | CANCER | | 17367315 | Transcription profiling of human ovarian cancer tumor samples to investigate heterogeneity |
OVARIAN.CANCER__CANCER | GSE12172 | 90 | 12 | CANCER | | 19010816 | Common activation of RAS_MAPK pathway in serous LMP tumours |
OVARIAN.CANCER__CANCER | GSE10971 | 37 | 13 | CANCER | | 18593983;21263043 | Gene expression data from non-malignant fallopian tube epithelium and high grade serous carcinoma. |
OVARIAN.CANCER__CANCER | GSE40595 | 77 | 69 | CANCER | | 23824740 | A cancer associated fibroblasts (CAFs) specific gene signature in high grade serous ovarian cancer |
OVARIAN.CANCER__NORMAL | GSE38666 | 45 | 20 | NORMAL | O | 23762861 | Molecular Profiling provides evidence of the existence of two functionally distinct classes of ovarian cancer stroma |
OVARIAN.CANCER__NORMAL | GSE29450 | 20 | 10 | NORMAL | - | 21754983 | Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers |
OVARIAN.CANCER__NORMAL | GSE36668 | 12 | 4 | NORMAL | - | 23029477 | Expression data from serous ovarian carcinomas, serous ovarian borderline tumors and surface epithelium scrapings from normal ovaries |
OVARIAN.CANCER__NORMAL | GSE15578 | 17 | 6 | NORMAL | - | - | Expression Data from Ovarian Surface Kinome |
OVARIAN.CANCER__NORMAL | GSE7307 | 677 | 7 | NORMAL | - | - | Human body index - transcriptional profiling |
OVARIAN.CANCER__NORMAL | GSE3526 | 353 | 1 | NORMAL | - | 16572319 | Comparison of gene expression profiles across the normal human body |
OVARIAN.CANCER__NORMAL | GSE43346 | 70 | 1 | NORMAL | - | 23714854 | Gene repression with H3K27me3 modification in human small cell lung cancer |
OVARIAN.CANCER__NORMAL | GSE40595 | 77 | 8 | NORMAL | - | 23824740 | A cancer associated fibroblasts (CAFs) specific gene signature in high grade serous ovarian cancer |
OVARIAN.CANCER__NORMAL | GSE28044 | 24 | 24 | NORMAL | O | 21744340 | Expression data from non-malignant fallopian tube epithelium |
PANCREATIC.CANCER__CANCER | GSE19650 | 22 | 15 | CANCER | | 20955708 | Expression data from epithelial cells during the process of multistep pancreatic carcinogenesis |
PANCREATIC.CANCER__CANCER | GSE39409 | 32 | 8 | CANCER | | - | Gene expression profiling of ampullary carcinomas classifies ampullary carcinomas into biliary-like and intestinal-like subtypes that are prognostic of outcome |
PANCREATIC.CANCER__CANCER | GSE42952 | 33 | 33 | CANCER | | 22925330 | Molecular markers associated with outcome and metastasis in human pancreatic cancer |
PANCREATIC.CANCER__CANCER | GSE16515 | 52 | 36 | CANCER | | 19732725 | Expression data from Mayo Clinic Pancreatic Tumor and Normal samples |
PANCREATIC.CANCER__CANCER | GSE17891 | 62 | 27 | CANCER | | 21460848 | Pervasive subtypes of pancreatic ductal adenocarcinoma (PDA) and their differing response to therapy. |
PANCREATIC.CANCER__CANCER | GSE32676 | 32 | 25 | CANCER | | 22261810 | Integrative Survival-Based Molecular Profiling of Human Pancreatic Cancer [mRNA] |
PANCREATIC.CANCER__CANCER | GSE22780 | 16 | 8 | CANCER | | - | Affymetrix Arrays Interrogated with Tumor/Normal Pancreatic Samples |
PANCREATIC.CANCER__CANCER | GSE15471 | 78 | 39 | CANCER | | 19260470 | Whole-Tissue Gene Expression Study of Pancreatic Ductal Adenocarcinoma |
PANCREATIC.CANCER__CANCER | E-MEXP-2780 | 31 | 30 | CANCER | | - | Survival in Pancreatic Cancer |
PANCREATIC.CANCER__NORMAL | GSE19650 | 22 | 7 | NORMAL | - | 20955708 | Expression data from epithelial cells during the process of multistep pancreatic carcinogenesis |
PANCREATIC.CANCER__NORMAL | GSE16515 | 52 | 16 | NORMAL | - | 19732725 | Expression data from Mayo Clinic Pancreatic Tumor and Normal samples |
PANCREATIC.CANCER__NORMAL | E-MEXP-1140 | 21 | 6 | NORMAL | - | - | Transcription profiling of human pancreas from patients with type 1 diabetes (clinical onset and longstanding) |
PANCREATIC.CANCER__NORMAL | GSE32676 | 32 | 7 | NORMAL | - | 22261810 | Integrative Survival-Based Molecular Profiling of Human Pancreatic Cancer [mRNA] |
PANCREATIC.CANCER__NORMAL | GSE22780 | 16 | 8 | NORMAL | O | - | Affymetrix Arrays Interrogated with Tumor/Normal Pancreatic Samples |
PANCREATIC.CANCER__NORMAL | GSE15471 | 78 | 39 | NORMAL | O | 19260470 | Whole-Tissue Gene Expression Study of Pancreatic Ductal Adenocarcinoma |
PANCREATIC.CANCER__NORMAL | GSE43346 | 70 | 1 | NORMAL | - | 23714854 | Gene repression with H3K27me3 modification in human small cell lung cancer |
PERITONEAL.CANCER__CANCER | GSE9890 | 10 | 5 | CANCER | | 18698038 | Expression profile of 5 ovarian tumour samples (two different cell types from each sample profiles) |
PERITONEAL.CANCER__NORMAL | E-MTAB-694 | 58 | 21 | NORMAL | O | - | Peritoneal endometriosis |
PITUITARY.CANCER__CANCER | GSE4237 | 10 | 8 | CANCER | | - | Hussaini-2R01NS035122-06A1 |
PITUITARY.CANCER__CANCER | GSE26966 | 23 | 14 | CANCER | | 21810943 | Identification of Growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a Novel Tumor Suppressor in Pituitary Gonadotrope Tumors |
PITUITARY.CANCER__NORMAL | GSE3526 | 353 | 2 | NORMAL | - | 16572319 | Comparison of gene expression profiles across the normal human body |
PITUITARY.CANCER__NORMAL | GSE26966 | 23 | 9 | NORMAL | - | 21810943 | Identification of Growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a Novel Tumor Suppressor in Pituitary Gonadotrope Tumors |
PITUITARY.CANCER__NORMAL | GSE7307 | 677 | 5 | NORMAL | - | - | Human body index - transcriptional profiling |
PROSTATE.CANCER__CANCER-LIKE | E-MEXP-1243 | 82 | 67 | CANCER-LIKE | | 18596959 | Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype |
PROSTATE.CANCER__CANCER-LIKE | GSE55945 | 21 | 6 | CANCER-LIKE | | 19737960 | Gene Expression Profiling of Prostate Benign and Malignant Tissue |
PROSTATE.CANCER__CANCER-LIKE | GSE31323 | 2 | 2 | CANCER-LIKE | | - | Different expressed genes in epithelium and stromal of Benign Prostatic Hyperplasia |
PROSTATE.CANCER__CANCER | GSE6369 | 2 | 2 | CANCER | | - | Prostate Adenocarcinoma Progression |
PROSTATE.CANCER__CANCER | E-MEXP-1243 | 82 | 14 | CANCER | | 18596959 | Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype |
PROSTATE.CANCER__CANCER | GSE30522 | 17 | 5 | CANCER | | - | Transcriptomes of human bladder cells and cells in bladder cancer |
PROSTATE.CANCER__CANCER | GSE7307 | 677 | 8 | CANCER | | - | Human body index - transcriptional profiling |
PROSTATE.CANCER__CANCER | GSE17951 | 154 | 109 | CANCER | | 20663908;21459804 | Gene expression analysis of prostate cancer samples using Affymetrix U133Plus2 array |
PROSTATE.CANCER__CANCER | GSE3325 | 19 | 2 | CANCER | | 16286247 | Integrative Genomic and Proteomic Analysis of Prostate Cancer Reveals Signatures of Metastatic Progression |
PROSTATE.CANCER__CANCER | GSE32448 | 80 | 40 | CANCER | | 22343836 | CPDR tumor-benign 80 genechip dataset |
PROSTATE.CANCER__CANCER | GSE45016 | 11 | 10 | CANCER | | 19956859 | Expression data from High-grade prostate cancer cells |
PROSTATE.CANCER__CANCER | GSE55945 | 21 | 12 | CANCER | | 19737960 | Gene Expression Profiling of Prostate Benign and Malignant Tissue |
PROSTATE.CANCER__NORMAL | GSE30522 | 17 | 5 | NORMAL | - | - | Transcriptomes of human bladder cells and cells in bladder cancer |
PROSTATE.CANCER__NORMAL | GSE7307 | 677 | 13 | NORMAL | - | - | Human body index - transcriptional profiling |
PROSTATE.CANCER__NORMAL | GSE17951 | 154 | 13 | NORMAL | O | 20663908;21459804 | Gene expression analysis of prostate cancer samples using Affymetrix U133Plus2 array |
PROSTATE.CANCER__NORMAL | GSE32448 | 80 | 40 | NORMAL | - | 22343836 | CPDR tumor-benign 80 genechip dataset |
PROSTATE.CANCER__NORMAL | GSE43346 | 70 | 1 | NORMAL | - | 23714854 | Gene repression with H3K27me3 modification in human small cell lung cancer |
PROSTATE.CANCER__NORMAL | GSE45016 | 11 | 1 | NORMAL | - | 19956859 | Expression data from High-grade prostate cancer cells |
RECTAL.CANCER__CANCER-LIKE | GSE8671 | 64 | 6 | CANCER-LIKE | | 18171984 | Transcriptome profile of human colorectal adenomas. |
RECTAL.CANCER__CANCER | E-MTAB-2387 | 73 | 69 | CANCER | | - | High-resolution analysis of DNA copy number alterations in rectal cancer |
RECTAL.CANCER__CANCER | GSE26027 | 12 | 12 | CANCER | | - | Early dynamic transcriptomic changes as predictors of preoperative radiotherapy efficacy in patients with rectal cancer: a feasibility study. |
RECTAL.CANCER__CANCER | GSE35452 | 46 | 45 | CANCER | | - | Prediction of sensitivity of rectal cancer cells in response to preoperative chemoradiotherapy by DNA microarray analysis of gene expression profiles. |
RECTAL.CANCER__CANCER | GSE28702 | 83 | 23 | CANCER | | 22095227 | CRC samples for FOLFOX therapy prediction |
RECTAL.CANCER__CANCER | GSE14333 | 290 | 39 | CANCER | | 19996206 | Expression data from 290 primary colorectal cancers |
RECTAL.CANCER__CANCER | GSE20916 | 145 | 15 | CANCER | | 20957034 | Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data |
RECTAL.CANCER__NORMAL | GSE8671 | 64 | 7 | NORMAL | O | 18171984 | Transcriptome profile of human colorectal adenomas. |
RECTAL.CANCER__NORMAL | GSE9254 | 19 | 6 | NORMAL | - | 18056783 | Normal human colorectal mucosa, cecum, ascending, transverse, sigmoid and rectum |
RECTAL.CANCER__NORMAL | GSE20916 | 145 | 7 | NORMAL | - | 20957034 | Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data |
RENAL.CANCER__CANCER | GSE36895 | 76 | 29 | CANCER | | 22683710 | Molecular Genetic Classification of clear-cell Renal Cell Carcinoma (ccRCC) based on the Gene Expression Profiling of Tumors and Tumorgrafts deficient for BAP1 or PBRM1 |
RENAL.CANCER__CANCER | GSE53757 | 144 | 72 | CANCER | | 24962026 | Gene array analysis of clear cell renal cell carcinoma tissue versus matched normal kidney tissue |
RENAL.CANCER__CANCER | GSE46699 | 130 | 67 | CANCER | | 24479813;24374825 | Smoking and Obesity Related Molecular Alterations in Clear Cell Renal Cell Carcinoma |
RENAL.CANCER__CANCER | GSE47352 | 9 | 9 | CANCER | | 24486593 | Identification of metastasis associated genes in clear cell renal cell carcinoma |
RENAL.CANCER__CANCER | GSE14378 | 20 | 20 | CANCER | | 19391132 | Expression data from pulmonary metastases of clear-cell renal cell carcinoma |
RENAL.CANCER__CANCER | GSE19982 | 30 | 30 | CANCER | | 20462447 | Gene expression discriminates chromophobe renal cell carcinoma and oncocytoma |
RENAL.CANCER__CANCER | E-TABM-282 | 28 | 16 | CANCER | | - | Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues |
RENAL.CANCER__CANCER | GSE19249 | 53 | 8 | CANCER | | 20522636 | Quantitative Gene Expression Profiling in Formalin-Fixed Paraffin-Embedded Samples by Affymetrix Microarrays |
RENAL.CANCER__CANCER | E-MTAB-1050 | 55 | 4 | CANCER | | - | Renal Cell Carcinoma (RCC) tumorgrafts exhibit similar gene expression profiling to corresponding primary tumors |
RENAL.CANCER__CANCER | GSE23629 | 32 | 32 | CANCER | | 20952505 | Expression data from RCC paired tumors to study metastasis progression |
RENAL.CANCER__CANCER | GSE11151 | 67 | 62 | CANCER | | 19445733;19680475;20440404 | Gene expression data from different types of renal tumors and normal kidneys |
RENAL.CANCER__CANCER | GSE12090 | 18 | 18 | CANCER | | 17145811 | Gene Expression Profiling Separates Chromophobe Renal Cell Carcinoma from Oncocytoma |
RENAL.CANCER__CANCER | GSE22541 | 68 | 44 | CANCER | | 22213152 | Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals |
RENAL.CANCER__NORMAL | GSE36895 | 76 | 23 | NORMAL | O | 22683710 | Molecular Genetic Classification of clear-cell Renal Cell Carcinoma (ccRCC) based on the Gene Expression Profiling of Tumors and Tumorgrafts deficient for BAP1 or PBRM1 |
RENAL.CANCER__NORMAL | GSE46699 | 130 | 63 | NORMAL | O | 24479813;24374825 | Smoking and Obesity Related Molecular Alterations in Clear Cell Renal Cell Carcinoma |
RENAL.CANCER__NORMAL | GSE7307 | 677 | 8 | NORMAL | - | - | Human body index - transcriptional profiling |
RENAL.CANCER__NORMAL | GSE53757 | 144 | 72 | NORMAL | - | 24962026 | Gene array analysis of clear cell renal cell carcinoma tissue versus matched normal kidney tissue |
RENAL.CANCER__NORMAL | E-TABM-282 | 28 | 11 | NORMAL | - | - | Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues |
RENAL.CANCER__NORMAL | GSE19249 | 53 | 8 | NORMAL | O | 20522636 | Quantitative Gene Expression Profiling in Formalin-Fixed Paraffin-Embedded Samples by Affymetrix Microarrays |
RENAL.CANCER__NORMAL | GSE43346 | 70 | 1 | NORMAL | - | 23714854 | Gene repression with H3K27me3 modification in human small cell lung cancer |
RENAL.CANCER__NORMAL | E-MTAB-1050 | 55 | 2 | NORMAL | O | - | Renal Cell Carcinoma (RCC) tumorgrafts exhibit similar gene expression profiling to corresponding primary tumors |
RENAL.CANCER__NORMAL | GSE11151 | 67 | 5 | NORMAL | - | 19445733;19680475;20440404 | Gene expression data from different types of renal tumors and normal kidneys |
SARCOMA__CANCER-LIKE | GSE13319 | 106 | 76 | CANCER-LIKE | | 19622772 | Comparison of Human and Rat Uterine Leiomyoma: Identification of a Dysregulated mTOR Pathway |
SARCOMA__CANCER | GSE37371 | 39 | 19 | CANCER | | - | Expression data from Ewing's sarcoma tumor samples |
SARCOMA__CANCER | E-TABM-1202 | 102 | 101 | CANCER | | - | Transcriptional profiling by array of primary rhabdomyosarcoma samples with different PAX3/FOXO1 fusion gene status |
SARCOMA__CANCER | GSE23980 | 171 | 163 | CANCER | | 22080063 | Expression data from human soft tissue sarcomas with complex genomics |
SARCOMA__CANCER | GSE58697 | 128 | 128 | CANCER | | 25878329 | Expression data from 128 Desmoids |
SARCOMA__CANCER | GSE20196 | 34 | 34 | CANCER | | 20975339 | Gene expression profile of poorly differentiated synovial sarcoma |
SARCOMA__CANCER | GSE14827 | 27 | 27 | CANCER | | 20159990;24448647 | Gene expression profiles from osteosarcpma samples |
SARCOMA__CANCER | GSE17674 | 62 | 44 | CANCER | | 22084725 | Inflammatory gene profiling of Ewing sarcoma family of tumors (set B) |
SARCOMA__CANCER | GSE21050 | 310 | 176 | CANCER | | 20581836 | Expression data from Complex genetics sarcomas (cohort 1 and 2) |
SARCOMA__CANCER | E-MEXP-1922 | 34 | 7 | CANCER | | 19276386 | Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas |
SARCOMA__CANCER | GSE34620 | 117 | 117 | CANCER | | 22327514 | Expression profiling of Ewing sarcoma samples |
SARCOMA__CANCER | GSE12102 | 37 | 1 | CANCER | | 19307502 | Overcoming resistance to conventional drugs in Ewing’s sarcoma and identification of molecular predictors of outcome. |
SARCOMA__HISTOLOGICAL_TYPE__ASKIN | GSE17674 | 62 | 1 | CANCER | | 22084725 | Inflammatory gene profiling of Ewing sarcoma family of tumors (set B) |
SARCOMA__HISTOLOGICAL_TYPE__DESMOID | GSE58697 | 128 | 127 | CANCER | | 25878329 | Expression data from 128 Desmoids |
SARCOMA__HISTOLOGICAL_TYPE__EWING_SARCOMA | GSE34620 | 117 | 116 | CANCER | | 22327514 | Expression profiling of Ewing sarcoma samples |
SARCOMA__HISTOLOGICAL_TYPE__LEIOMYOSARCOMA | GSE21050 | 310 | 84 | CANCER | | 20581836 | Expression data from Complex genetics sarcomas (cohort 1 and 2) |
SARCOMA__HISTOLOGICAL_TYPE__LEIOMYOSARCOMA | E-MEXP-1922 | 34 | 9 | CANCER | | 19276386 | Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas |
SARCOMA__HISTOLOGICAL_TYPE__LIPOSARCOMA | GSE21050 | 310 | 61 | CANCER | | 20581836 | Expression data from Complex genetics sarcomas (cohort 1 and 2) |
SARCOMA__HISTOLOGICAL_TYPE__LIPOSARCOMA | GSE16382 | 183 | 8 | CANCER | | - | Expression data from complex genetic sarcomas |
SARCOMA__HISTOLOGICAL_TYPE__RHABDOMYOSARCOMA | E-TABM-1202 | 102 | 101 | CANCER | | - | Transcriptional profiling by array of primary rhabdomyosarcoma samples with different PAX3/FOXO1 fusion gene status |
SARCOMA__HISTOLOGICAL_TYPE__RHABDOMYOSARCOMA | GSE16382 | 183 | 7 | CANCER | | - | Expression data from complex genetic sarcomas |
SARCOMA__HISTOLOGICAL_TYPE__SYNOVIAL_SARCOMA | GSE20196 | 34 | 33 | CANCER | | 20975339 | Gene expression profile of poorly differentiated synovial sarcoma |
SARCOMA__NORMAL.OF.LEIOMYOSARCOMA | GSE9103 | 40 | 40 | NORMAL | - | - | Skeletal Muscle Transcript Profiles in Trained or Sedentary Young and Old Subjects |
SARCOMA__NORMAL.OF.LEIOMYOSARCOMA | E-MEXP-2559 | 36 | 30 | NORMAL | - | 19668377 | Gene expression profiling in diabetic skeletal muscle |
SARCOMA__NORMAL.OF.LEIOMYOSARCOMA | GSE19420 | 42 | 12 | NORMAL | - | 22802091 | Skeletal muscle mitochondrial dysfunction is secondary to T2DM |
SARCOMA__NORMAL.OF.LEIOMYOSARCOMA | GSE43346 | 70 | 1 | NORMAL | - | 23714854 | Gene repression with H3K27me3 modification in human small cell lung cancer |
SARCOMA__NORMAL.OF.LEIOMYOSARCOMA | GSE6798 | 29 | 13 | NORMAL | - | 17563058 | Reduced expression of mitochondrial oxidative metabolism genes in skeletal muscle of women with PCOS |
SARCOMA__NORMAL.OF.LEIOMYOSARCOMA | GSE28998 | 14 | 14 | NORMAL | O | 22052873 | Human skeletal muscle transcriptional response to exercise |
SARCOMA__NORMAL.OF.LEIOMYOSARCOMA | GSE7307 | 677 | 27 | NORMAL | - | - | Human body index - transcriptional profiling |
SARCOMA__NORMAL.OF.LEIOMYOSARCOMA | GSE9419 | 66 | 65 | NORMAL | - | 20149619 | The skeletal muscle transcript profile reflects responses to inadequate protein intake in younger and older males |
SARCOMA__NORMAL.OF.LEIOMYOSARCOMA | GSE15090 | 15 | 5 | NORMAL | - | 19339494 | Gene expression profiles in muscle tissue from FSHD patients |
SARCOMA__NORMAL.OF.LEIOMYOSARCOMA | GSE47881 | 89 | 89 | NORMAL | O | 23555298 | Impact of resistance exercise on human skeletal muscle gene expression - ageing |
SARCOMA__NORMAL.OF.LEIOMYOSARCOMA | GSE7014 | 36 | 6 | NORMAL | - | 20066428;20971734 | Expression data from DM1, DM2 and Normal Adult Skeletal Muscle Biopsies |
SARCOMA__NORMAL.OF.LEIOMYOSARCOMA | GSE34111 | 30 | 30 | NORMAL | - | 22452944 | Gene expression in skeletal muscle of cancer patients before and after potentially curative surgery |
SARCOMA__NORMAL.OF.LEIOMYOSARCOMA | GSE3526 | 353 | 2 | NORMAL | - | 16572319 | Comparison of gene expression profiles across the normal human body |
SARCOMA__NORMAL.OF.LEIOMYOSARCOMA | GSE13205 | 21 | 8 | NORMAL | - | 18997871 | Skeletal muscle transcriptome in ICU patients suffering from sepsis induced multiple organ failure |
SARCOMA__NORMAL.OF.LEIOMYOSARCOMA | GSE12474 | 10 | 10 | NORMAL | O | 20803152 | Microarray analysis of skeletal muscle hypertrophy induced by heat-stress in healthy humans |
SARCOMA__NORMAL.OF.LEIOMYOSARCOMA | GSE22435 | 17 | 10 | NORMAL | - | 21803291 | Expression of Splicing Factor Genes is Reduced in Human Obesity and Contributes to Enhanced Lipogenesis |
SARCOMA__NORMAL.OF.LEIOMYOSARCOMA | GSE28422 | 110 | 110 | NORMAL | - | 22302958 | Effects of resistance exercise and resistance training on the skeletal muscle transcriptome in young and old adults |
SARCOMA__NORMAL.OF.LEIOMYOSARCOMA | GSE24235 | 28 | 14 | NORMAL | - | 21106073 | Skeletal muscle gene expression in response to resistance exercise: sex specific regulation |
SARCOMA__NORMAL.OF.LEIOMYOSARCOMA | GSE25941 | 36 | 36 | NORMAL | - | 22302958 | Effects of age on the skeletal muscle transcriptome |
SARCOMA__NORMAL.OF.LEIOMYOSARCOMA | GSE35659 | 24 | 24 | NORMAL | - | 20930125 | A transcriptional map of the impact of endurance exercise training on skeletal muscle phenotype (resting muscle after endurance training) |
SARCOMA__NORMAL.OF.LEIOMYOSARCOMA | GSE38718 | 22 | 22 | NORMAL | - | 23418191 | Sex and aging effect on skeletal muscle transcriptome in humans |
SARCOMA__NORMAL.OF.LIPOSARCOMA | GSE27657 | 18 | 18 | NORMAL | - | 21125211;23264395 | Human subcutaneous adipose tissue and perithyroid adipose tissue gene expression |
SARCOMA__NORMAL.OF.LIPOSARCOMA | GSE7307 | 677 | 10 | NORMAL | - | - | Human body index - transcriptional profiling |
SARCOMA__NORMAL.OF.LIPOSARCOMA | GSE27916 | 375 | 375 | NORMAL | - | 23264395;23511207 | Human subcutaneous adipose tissue gene expression (SOS Sib-pair study, offspring cohort) |
SARCOMA__NORMAL.OF.LIPOSARCOMA | GSE17170 | 70 | 70 | NORMAL | - | 19750004 | A systems genetics approach implicates USF1, FADS3 and other causal candidate genes for familial combined hyperlipidemia |
SARCOMA__NORMAL.OF.LIPOSARCOMA | GSE9624 | 11 | 5 | NORMAL | - | - | Differential gene expression in omental adipose tissue from obese children |
SARCOMA__NORMAL.OF.LIPOSARCOMA | GSE43346 | 70 | 1 | NORMAL | - | 23714854 | Gene repression with H3K27me3 modification in human small cell lung cancer |
SARCOMA__NORMAL.OF.SYNOVIAL_SARCOMA | GSE7307 | 677 | 3 | NORMAL | - | - | Human body index - transcriptional profiling |
SKIN.CANCER__CANCER | GSE7553 | 87 | 2 | CANCER | | 18442402 | Gene Expression Patterns Involved in the Malignant Transformation and Progression of Metastatic Melanoma |
SKIN.CANCER__CANCER | GSE34599 | 21 | 21 | CANCER | | - | In-transit extremity melanoma III |
SKIN.CANCER__CANCER | GSE7307 | 677 | 3 | CANCER | | - | Human body index - transcriptional profiling |
SKIN.CANCER__CANCER | GSE39612 | 138 | 36 | CANCER | | 23223137 | Distinct gene expression profiles of viral- and non-viral associated Merkel cell carcinoma revealed by transcriptome analysis |
SKIN.CANCER__CANCER | GSE31879 | 30 | 10 | CANCER | | - | Alterations of methylome and transcriptome in human melanoma: the inverse relationship between epigenome integrity and BRAF mutation |
SKIN.CANCER__CANCER | GSE19234 | 44 | 44 | CANCER | | 19915147 | Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival. |
SKIN.CANCER__CANCER | GSE19293 | 52 | 52 | CANCER | | 20371714 | In-transit extremity melanoma II |
SKIN.CANCER__CANCER | GSE23376 | 22 | 22 | CANCER | | - | Gene expression data from stage IV melanoma patients |
SKIN.CANCER__CANCER | GSE10282 | 43 | 3 | CANCER | | 20371714 | In-transit extremity melanoma I |
SKIN.CANCER__CANCER | GSE22968 | 28 | 28 | CANCER | | 21343562 | Phase II trial melphalan ILI plus ADH-1 for treatment of in-transit extremity melanoma |
SKIN.CANCER__CANCER | GSE15605 | 74 | 58 | CANCER | | 23633021 | Transcriptome profiling identifies HMGA2 as a novel gene in melanoma progression |
SKIN.CANCER__CANCER | GSE35640 | 65 | 65 | CANCER | | 23715562 | Identification of a predictive gene signature to recMAGE A3 antigen-specific cancer immunotherapy in metastatic melanoma and non-small-cell lung cancer |
SKIN.CANCER__NORMAL | GSE28914 | 25 | 8 | NORMAL | O | 23082929 | Human Skin Transcriptome during Epidermal Wound Healing |
SKIN.CANCER__NORMAL | GSE13355 | 180 | 58 | NORMAL | - | 19169254;21483750 | Gene expression data of skin from psoriatic patients and normal controls |
SKIN.CANCER__NORMAL | GSE43346 | 70 | 1 | NORMAL | - | 23714854 | Gene repression with H3K27me3 modification in human small cell lung cancer |
SKIN.CANCER__NORMAL | GSE34248 | 28 | 14 | NORMAL | - | 23308107 | Gene expression profiling in psoriatic lesional and non-lesional skin [Set 1] |
SKIN.CANCER__NORMAL | GSE46239 | 52 | 4 | NORMAL | - | - | Gene Expression Analysis of Dermatomyositis Skin |
SKIN.CANCER__NORMAL | GSE16161 | 33 | 1 | NORMAL | - | 20004782 | Broad defects in epidermal cornification in atopic dermatitis (AD) identified through genomic analysis |
SKIN.CANCER__NORMAL | GSE41663 | 81 | 15 | NORMAL | - | 23308107 | Re-analysis by microarray using cDNA target of samples from psoriasis patients enrolled in an etanercept trial |
SKIN.CANCER__NORMAL | GSE7307 | 677 | 7 | NORMAL | - | - | Human body index - transcriptional profiling |
SKIN.CANCER__NORMAL | GSE39612 | 138 | 64 | NORMAL | - | 23223137 | Distinct gene expression profiles of viral- and non-viral associated Merkel cell carcinoma revealed by transcriptome analysis |
SKIN.CANCER__NORMAL | GSE32924 | 33 | 20 | NORMAL | O | 21388663 | Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities |
SKIN.CANCER__NORMAL | GSE27887 | 35 | 9 | NORMAL | O | 21762976 | Reversal of Atopic Dermatitis with Narrow-Band UVB Phototherapy and Biomarkers for Therapeutic Response |
SKIN.CANCER__NORMAL | GSE30999 | 170 | 85 | NORMAL | - | 22763790 | Expression data from skin biopsy samples from patients with moderate-to-severe psoriasis |
SKIN.CANCER__NORMAL | GSE6281 | 34 | 16 | NORMAL | O | 17597826 | Gene expression time-course in the human skin during elicitation of allergic contact dermatitis |
SKIN.CANCER__NORMAL | GSE32887 | 31 | 5 | NORMAL | - | 21924794 | Molecular profiling and gene expression analysis in cutaneous sarcoidosis (CS) |
SKIN.CANCER__NORMAL | GSE14905 | 82 | 49 | NORMAL | - | 18648529 | Type I Interferon: Potential Therapeutic Target for Psoriasis? |
SKIN.CANCER__NORMAL | GSE15605 | 74 | 16 | NORMAL | - | 23633021 | Transcriptome profiling identifies HMGA2 as a novel gene in melanoma progression |
SMALL.INTESTINE.CANCER__NORMAL | GSE43346 | 70 | 1 | NORMAL | - | 23714854 | Gene repression with H3K27me3 modification in human small cell lung cancer |
SMALL.INTESTINE.CANCER__NORMAL | GSE7307 | 677 | 6 | NORMAL | - | - | Human body index - transcriptional profiling |
SMALL.INTESTINE.CANCER__NORMAL | GSE16879 | 133 | 6 | NORMAL | O | 19956723 | Mucosal expression profiling in patients with inflammatory bowel disease before and after first infliximab treatment |
SMALL.INTESTINE.CANCER__NORMAL | GSE9576 | 12 | 2 | NORMAL | - | 18953328 | Gene expression profiling of classical midgut carcinoid primary tumors and liver metastasis |
SPLEEN__NORMAL | GSE43346 | 70 | 1 | NORMAL | - | 23714854 | Gene repression with H3K27me3 modification in human small cell lung cancer |
SPLEEN__NORMAL | GSE7307 | 677 | 4 | NORMAL | - | - | Human body index - transcriptional profiling |
TESTIS.CANCER__NORMAL | GSE43346 | 70 | 1 | NORMAL | - | 23714854 | Gene repression with H3K27me3 modification in human small cell lung cancer |
TESTIS.CANCER__NORMAL | GSE7307 | 677 | 5 | NORMAL | - | - | Human body index - transcriptional profiling |
THYROID.CANCER__CANCER-LIKE | E-MEXP-2442 | 70 | 33 | CANCER-LIKE | | 20668010 | Transcription profiling of human thyroid gland cells to find molecular signatures of thyroid follicular neoplasia |
THYROID.CANCER__CANCER | GSE3467 | 18 | 9 | CANCER | | 16365291 | The role of micro-RNA genes in papillary thyroid carcinoma |
THYROID.CANCER__CANCER | GSE33630 | 105 | 60 | CANCER | | 22266856;22828612 | Normal thyrocytes vs papillary vs anaplastic thyroid carcinomas |
THYROID.CANCER__CANCER | GSE6004 | 18 | 14 | CANCER | | 17296934 | Gene Expression and Functional Evidence of Epithelial-to-Mesenchymal Transition in Papillary Thyroid Cancer Invasion |
THYROID.CANCER__CANCER | GSE29265 | 49 | 29 | CANCER | | - | Sporadic vs. Post-Chernobyl Papillary vs. Anaplastic Thyroid Cancers |
THYROID.CANCER__CANCER | E-MEXP-2442 | 70 | 24 | CANCER | | 20668010 | Transcription profiling of human thyroid gland cells to find molecular signatures of thyroid follicular neoplasia |
THYROID.CANCER__CANCER | GSE3678 | 14 | 7 | CANCER | | - | PTC versus paired normal thyroid tissue |
THYROID.CANCER__NORMAL | GSE3467 | 18 | 9 | NORMAL | O | 16365291 | The role of micro-RNA genes in papillary thyroid carcinoma |
THYROID.CANCER__NORMAL | GSE33630 | 105 | 45 | NORMAL | - | 22266856;22828612 | Normal thyrocytes vs papillary vs anaplastic thyroid carcinomas |
THYROID.CANCER__NORMAL | GSE6004 | 18 | 4 | NORMAL | O | 17296934 | Gene Expression and Functional Evidence of Epithelial-to-Mesenchymal Transition in Papillary Thyroid Cancer Invasion |
THYROID.CANCER__NORMAL | GSE7307 | 677 | 4 | NORMAL | - | - | Human body index - transcriptional profiling |
THYROID.CANCER__NORMAL | GSE29265 | 49 | 20 | NORMAL | O | - | Sporadic vs. Post-Chernobyl Papillary vs. Anaplastic Thyroid Cancers |
THYROID.CANCER__NORMAL | E-MEXP-2442 | 70 | 2 | NORMAL | - | 20668010 | Transcription profiling of human thyroid gland cells to find molecular signatures of thyroid follicular neoplasia |
THYROID.CANCER__NORMAL | GSE43346 | 70 | 2 | NORMAL | - | 23714854 | Gene repression with H3K27me3 modification in human small cell lung cancer |
THYROID.CANCER__NORMAL | GSE3678 | 14 | 7 | NORMAL | O | - | PTC versus paired normal thyroid tissue |
URETER.CANCER__CANCER | GSE31189 | 92 | 51 | CANCER | | 23097579 | Molecular Biomarker Signature for Bladder Cancer Detection |
URETER.CANCER__NORMAL | GSE31189 | 92 | 40 | NORMAL | - | 23097579 | Molecular Biomarker Signature for Bladder Cancer Detection |
URETER.CANCER__NORMAL | GSE7307 | 677 | 4 | NORMAL | - | - | Human body index - transcriptional profiling |
UTERINE.CANCER__CANCER-LIKE | GSE4888 | 27 | 12 | CANCER-LIKE | | 16306079 | Molecular phenotyping of human endometrium |
UTERINE.CANCER__CANCER | GSE9891 | 285 | 33 | CANCER | | 18698038 | Expression profile of 285 ovarian tumour samples |
UTERINE.CANCER__CANCER | GSE56026 | 75 | 63 | CANCER | | 25267067 | Gene expression in human endometrial cancer tissues and serous papillary endometrial cancer cell line, SPAC-1L, treated by STAT1-siRNA and/or IFN-gamma |
UTERINE.CANCER__CANCER | GSE26511 | 39 | 39 | CANCER | | 21385933 | Involvement of the TGF-β and β-catenin pathways in pelvic lymph node metastasis in early stage cervical cancer |
UTERINE.CANCER__CANCER | GSE29436 | 8 | 8 | CANCER | | - | Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer: patient data |
UTERINE.CANCER__CANCER | GSE6791 | 84 | 20 | CANCER | | 17510386 | Gene Expression Profiles of HPV-Positive and -Negative Head/Neck and Cervical Cancers |
UTERINE.CANCER__CANCER | GSE27678 | 77 | 28 | CANCER | | 17516585;21952923;23765377 | Gene expression analysis in a variety of normal, premalignant and squamous cell carcinomas of the cervix |
UTERINE.CANCER__CANCER | GSE5787 | 33 | 33 | CANCER | | 17020965 | Survey of Intra- and Inter-Tumour Heterogeneity of Gene Expression in Cervical Cancer |
UTERINE.CANCER__CANCER | GSE18096 | 27 | 18 | CANCER | | 22343407 | Identifying the molecular signature of the t(12;14) subgroup of uterine leiomyomata using a paired analysis |
UTERINE.CANCER__CANCER | GSE17025 | 103 | 103 | CANCER | | 21619611 | Gene Expression Analysis of Stage I Endometrial Cancers |
UTERINE.CANCER__NORMAL | GSE6364 | 37 | 16 | NORMAL | - | 17510236 | Gene Profiling of Endometrium Reveals Progesterone Resistance and Candidate Genetic Loci in Women with Endometriosis |
UTERINE.CANCER__NORMAL | GSE29981 | 20 | 20 | NORMAL | - | - | Expression data from human endometrium |
UTERINE.CANCER__NORMAL | GSE7305 | 20 | 1 | NORMAL | - | 17640886 | Human endometriosis vs normal endometrium study - transcriptional profiling |
UTERINE.CANCER__NORMAL | GSE7846 | 10 | 4 | NORMAL | - | 17956924 | Differentially expressed genes in HEECs of eutopic endometrium of patients with endometriosis compared with control |
UTERINE.CANCER__NORMAL | GSE7307 | 677 | 28 | NORMAL | - | - | Human body index - transcriptional profiling |
UTERINE.CANCER__NORMAL | GSE6791 | 84 | 8 | NORMAL | - | 17510386 | Gene Expression Profiles of HPV-Positive and -Negative Head/Neck and Cervical Cancers |
UTERINE.CANCER__NORMAL | GSE27678 | 77 | 3 | NORMAL | - | 17516585;21952923;23765377 | Gene expression analysis in a variety of normal, premalignant and squamous cell carcinomas of the cervix |
UTERINE.CANCER__NORMAL | GSE43346 | 70 | 1 | NORMAL | - | 23714854 | Gene repression with H3K27me3 modification in human small cell lung cancer |
UVEAL.MELANOMA__CANCER | GSE27831 | 29 | 28 | CANCER | | 22267972 | Syntenin-1 is expressed in uveal melanoma and correlates with metastatic progression |
VULVAR.CANCER__CANCER-LIKE | GSE5563 | 19 | 8 | CANCER-LIKE | | 17471573;21815142 | Gene expression profile of VIN lesions in comparison to controls |
VULVAR.CANCER__NORMAL | GSE7307 | 677 | 7 | NORMAL | - | - | Human body index - transcriptional profiling |
VULVAR.CANCER__NORMAL | GSE5563 | 19 | 10 | NORMAL | - | 17471573;21815142 | Gene expression profile of VIN lesions in comparison to controls |